<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Integrated Mini Test 12 - Pharmacology - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Mini Test Series / 2024-25
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">20</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x291fca=_0x2268;(function(_0x5d6ebf,_0x1eea67){const _0x387313=_0x2268,_0x226b2d=_0x5d6ebf();while(!![]){try{const _0x1c26b1=parseInt(_0x387313(0x1e3))/0x1*(-parseInt(_0x387313(0x1bc))/0x2)+-parseInt(_0x387313(0x3aa))/0x3+-parseInt(_0x387313(0x23a))/0x4*(parseInt(_0x387313(0x313))/0x5)+parseInt(_0x387313(0x2e9))/0x6+parseInt(_0x387313(0x323))/0x7*(parseInt(_0x387313(0x295))/0x8)+-parseInt(_0x387313(0x2dc))/0x9+parseInt(_0x387313(0x2af))/0xa;if(_0x1c26b1===_0x1eea67)break;else _0x226b2d['push'](_0x226b2d['shift']());}catch(_0x378812){_0x226b2d['push'](_0x226b2d['shift']());}}}(_0x2504,0xea282));const _0x2e4b21=(function(){const _0x16d8fb=_0x2268,_0x3aeb4a={'zkxQU':function(_0x1af67d,_0x42447a){return _0x1af67d!==_0x42447a;},'kHHPQ':_0x16d8fb(0xf7)};let _0x3b30cf=!![];return function(_0x8b2f3b,_0x3d68af){const _0x2efaa0=_0x16d8fb;if(_0x3aeb4a[_0x2efaa0(0xfa)](_0x3aeb4a[_0x2efaa0(0x187)],_0x3aeb4a['kHHPQ'])){if(!_0x5b377d)_0x90e479();_0x125bca[_0x2efaa0(0x243)][_0x2efaa0(0x26d)]=_0xd65400[_0x2efaa0(0x322)]||_0x2efaa0(0x272);}else{const _0x28ecbb=_0x3b30cf?function(){if(_0x3d68af){const _0x406fa6=_0x3d68af['apply'](_0x8b2f3b,arguments);return _0x3d68af=null,_0x406fa6;}}:function(){};return _0x3b30cf=![],_0x28ecbb;}};}()),_0x3b8b25=_0x2e4b21(this,function(){const _0x15f399=_0x2268,_0x56a786={'oYBbH':_0x15f399(0x275)};return _0x3b8b25['toString']()[_0x15f399(0x265)](_0x56a786[_0x15f399(0x168)])[_0x15f399(0x14c)]()[_0x15f399(0x2a2)](_0x3b8b25)[_0x15f399(0x265)](_0x56a786[_0x15f399(0x168)]);});_0x3b8b25();const _0x14f47c=(function(){const _0x384b43=_0x2268,_0x298c1e={'pDVsY':_0x384b43(0x2ce),'dZxDx':'customQuizData','RxMHf':function(_0x551d32){return _0x551d32();},'mFshP':function(_0x50de1b,_0x20b270,_0x55ae29){return _0x50de1b(_0x20b270,_0x55ae29);},'nXXTJ':function(_0xfd0729,_0x17e2a3){return _0xfd0729===_0x17e2a3;},'KgNMO':_0x384b43(0x2b2)};let _0x3c3988=!![];return function(_0x949d38,_0x1c53f3){const _0x5a3d5c=_0x384b43,_0x48e110={'zLuBW':_0x298c1e[_0x5a3d5c(0x281)],'rATRM':_0x298c1e[_0x5a3d5c(0x388)],'hDeur':function(_0x1943f1){return _0x298c1e['RxMHf'](_0x1943f1);},'TItqC':function(_0x366e2e,_0x1e9f65,_0x593a7d){const _0x13b6f7=_0x5a3d5c;return _0x298c1e[_0x13b6f7(0x1b7)](_0x366e2e,_0x1e9f65,_0x593a7d);},'WoQrI':function(_0x5f17bb,_0x3a0941){return _0x298c1e['nXXTJ'](_0x5f17bb,_0x3a0941);},'niopM':_0x298c1e[_0x5a3d5c(0x1c6)],'zzPvm':function(_0x2b5992,_0x384cba){const _0x4b6567=_0x5a3d5c;return _0x298c1e[_0x4b6567(0x2f6)](_0x2b5992,_0x384cba);},'hyFgR':'WKxGS'},_0x1f1340=_0x3c3988?function(){const _0x1f9e2e=_0x5a3d5c,_0x3b5c9f={'JSXhJ':function(_0x23116d,_0x16b5b7,_0x1ec851){const _0x46e07a=_0x2268;return _0x48e110[_0x46e07a(0x159)](_0x23116d,_0x16b5b7,_0x1ec851);}};if(_0x48e110['WoQrI'](_0x48e110[_0x1f9e2e(0x1c9)],_0x48e110[_0x1f9e2e(0x1c9)])){if(_0x1c53f3){if(_0x48e110[_0x1f9e2e(0x25c)](_0x48e110[_0x1f9e2e(0x339)],_0x48e110['hyFgR'])){const _0x1a1db0=_0x1c53f3[_0x1f9e2e(0x15e)](_0x949d38,arguments);return _0x1c53f3=null,_0x1a1db0;}else _0x29b0b6[_0x1f9e2e(0x243)]['pathname'][_0x1f9e2e(0x1d1)](_0x48e110[_0x1f9e2e(0x16a)])&&_0x58e669[_0x1f9e2e(0x1e2)](_0x48e110[_0x1f9e2e(0x31f)]),_0x48e110[_0x1f9e2e(0x161)](_0x252288),_0xab6e11[_0x1f9e2e(0x340)]();}}else _0x3b5c9f[_0x1f9e2e(0x213)](_0x5ee93d,_0x54484c,_0x4cd1d2);}:function(){};return _0x3c3988=![],_0x1f1340;};}()),_0x183107=_0x14f47c(this,function(){const _0x3d728a=_0x2268,_0x441c9e={'vNJPP':_0x3d728a(0x1af),'oAMsS':_0x3d728a(0x113),'jBaXg':_0x3d728a(0x3ba),'MEOZO':_0x3d728a(0x271),'VPyzK':function(_0x1a1aa0,_0x283b49){return _0x1a1aa0(_0x283b49);},'bizdO':function(_0x48b51e,_0x75342d){return _0x48b51e+_0x75342d;},'aNfDa':_0x3d728a(0x164),'NArvL':_0x3d728a(0x241),'wPhvY':function(_0x17ff5f,_0x21ef72){return _0x17ff5f===_0x21ef72;},'EQFlG':_0x3d728a(0x32d),'LOolG':function(_0x34db6b){return _0x34db6b();},'cEIkr':_0x3d728a(0x384),'kqzSZ':_0x3d728a(0x2f2),'TSeFb':'info','mnDQZ':_0x3d728a(0x382),'Tpmhy':_0x3d728a(0x2a8),'kzqBe':_0x3d728a(0x368),'WUHmC':function(_0x2813d1,_0xc7e5fa){return _0x2813d1<_0xc7e5fa;}},_0x31ab51=function(){const _0x9cd5dd=_0x3d728a;if(_0x441c9e[_0x9cd5dd(0x258)]===_0x441c9e[_0x9cd5dd(0x258)]){let _0x5ca3bc;try{_0x441c9e[_0x9cd5dd(0x1a6)]!==_0x9cd5dd(0x271)?_0x9ff9b4[_0x9cd5dd(0x2fd)](_0x441c9e['vNJPP'])[_0x9cd5dd(0x365)]['add'](_0x441c9e[_0x9cd5dd(0x372)]):_0x5ca3bc=_0x441c9e['VPyzK'](Function,_0x441c9e['bizdO'](_0x441c9e[_0x9cd5dd(0x276)](_0x441c9e[_0x9cd5dd(0x363)],_0x441c9e[_0x9cd5dd(0x380)]),');'))();}catch(_0x450e3d){_0x441c9e[_0x9cd5dd(0x3a1)]('Ynaqy',_0x441c9e[_0x9cd5dd(0x328)])?_0x5ca3bc=window:_0x278c51[_0x9cd5dd(0x2c2)]=_0x4fcfe3;}return _0x5ca3bc;}else _0x598e1d[_0x3f7165[_0x9cd5dd(0x1da)]][_0x9cd5dd(0x14d)]=!![];},_0x36850d=_0x441c9e['LOolG'](_0x31ab51),_0x278da4=_0x36850d[_0x3d728a(0x37c)]=_0x36850d[_0x3d728a(0x37c)]||{},_0x22419a=[_0x441c9e['cEIkr'],_0x441c9e[_0x3d728a(0x104)],_0x441c9e[_0x3d728a(0x212)],_0x441c9e[_0x3d728a(0x233)],_0x441c9e[_0x3d728a(0x31b)],_0x441c9e['kzqBe'],'trace'];for(let _0x44769b=0x0;_0x441c9e[_0x3d728a(0x10f)](_0x44769b,_0x22419a[_0x3d728a(0x1eb)]);_0x44769b++){const _0x7c9630=_0x14f47c[_0x3d728a(0x2a2)][_0x3d728a(0x1a0)][_0x3d728a(0x229)](_0x14f47c),_0x10b2fc=_0x22419a[_0x44769b],_0x3b0f4b=_0x278da4[_0x10b2fc]||_0x7c9630;_0x7c9630[_0x3d728a(0x344)]=_0x14f47c[_0x3d728a(0x229)](_0x14f47c),_0x7c9630[_0x3d728a(0x14c)]=_0x3b0f4b['toString']['bind'](_0x3b0f4b),_0x278da4[_0x10b2fc]=_0x7c9630;}});_0x183107();let questionsData=[{'text':_0x291fca(0x39e),'choices':[{'id':0x1,'text':'Adriamycin'},{'id':0x2,'text':_0x291fca(0x16d)},{'id':0x3,'text':_0x291fca(0x2c4)},{'id':0x4,'text':_0x291fca(0x361)}],'correct_choice_id':0x2,'solution':_0x291fca(0x214),'explanation_video':'','question_images':[],'explanation_images':[_0x291fca(0x23b)]},{'text':_0x291fca(0x117),'choices':[{'id':0x1,'text':'Ramucirumab'},{'id':0x2,'text':'Sunitinib'},{'id':0x3,'text':_0x291fca(0xed)},{'id':0x4,'text':_0x291fca(0x1f9)}],'correct_choice_id':0x2,'solution':_0x291fca(0x201),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x11d),'choices':[{'id':0x1,'text':_0x291fca(0xf0)},{'id':0x2,'text':'Pilocarpine'},{'id':0x3,'text':'Acetazolamide'},{'id':0x4,'text':_0x291fca(0x2cf)}],'correct_choice_id':0x4,'solution':_0x291fca(0x245),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2030-year-old\x20female\x20patient\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20complaints\x20of\x20chest\x20pain\x20and\x20palpitations.\x20ECG\x20strip\x20obtained\x20is\x20shown\x20in\x20the\x20image\x20below.\x20His\x20BP\x20is\x20120/76\x20mm\x20Hg.\x20Vagal\x20maneuvers\x20were\x20tried\x20but\x20failed.\x20What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20this\x20condition?','choices':[{'id':0x1,'text':_0x291fca(0x2f1)},{'id':0x2,'text':_0x291fca(0x35d)},{'id':0x3,'text':_0x291fca(0x235)},{'id':0x4,'text':_0x291fca(0x2ab)}],'correct_choice_id':0x4,'solution':'<p>This\x20ECG\x20strip&nbsp;is\x20suggestive\x20of\x20the\x20AV\x20nodal\x20reentry\x20(<strong>AVNRT</strong>)\x20variant\x20of&nbsp;<strong>paroxysmal\x20supraventricular\x20tachycardia\x20(PSVT).\x20</strong>The\x20drug\x20of\x20choice\x20for\x20the\x20termination\x20of\x20PSVT\x20is\x20<strong>adenosine.</strong><strong>&nbsp;</strong></p>\x0a<div\x20class=\x22O0\x22>\x0a<p>PSVT\x20spans\x20a\x20variety\x20of\x20tachycardia\x20that\x20differ\x20based\x20on\x20the\x20pathway\x20of\x20impulse\x20conduction.\x20They\x20include\x20AV\x20node\x20reentry,\x20AV\x20reentry\x20via\x20an\x20accessory\x20pathway,\x20and\x20atrial\x20tachycardia.\x20AVNRT\x20is\x20the\x20most\x20commonly\x20seen\x20pattern\x20of\x20PSVT\x20in\x20healthy\x20adults,\x20especially\x20in\x20women.\x20This\x20form\x20of\x20PSVT\x20is\x20due\x20to\x20the\x20re-entry\x20of\x20the\x20electrical\x20impulse\x20from\x20the\x20AV\x20node\x20to\x20the\x20right\x20atrium\x20via\x20either\x20of\x20the\x202\x20pathways\x20(superior\x20fast\x20pathway\x20and\x20inferior\x20slow\x20pathway).</p>\x0a<p>The\x20given\x20ECG\x20strip\x20shows\x20changes\x20suggestive\x20of\x20<strong>AV\x20node\x20reentry\x20tachycardia</strong>\x20based\x20on\x20the\x20following\x20findings-</p>\x0a<ul>\x0a<li><strong>Narrow\x20QRS\x20complex</strong>\x20tachycardia\x20(green\x20arrows)\x20at\x20150\x20bpm\x20-\x20indicative\x20of\x20a\x20regular\x20atrial\x20rate\x20(<strong>1:1\x20AV\x20response</strong>).\x20Heart\x20rate\x20is\x20calculated\x20by\x20dividing\x20300\x20by\x20the\x20number\x20of\x20large\x20boxes\x20between\x202\x20consecutive\x20R\x20waves.\x20The\x20ECG\x20strip\x20shows\x20the\x20presence\x20of\x20roughly\x202\x20large\x20boxes\x20between\x202\x20consecutive\x20R\x20waves,\x20thereby\x20making\x20the\x20HR\x20~150\x20bpm.&nbsp;</li>\x0a<li><strong>No\x20visible\x20P\x20waves</strong>\x20-\x20indicative\x20of\x20dual\x20conduction\x20pathways\x20(slow\x20and\x20fast)\x20that\x20cause\x20simultaneous\x20atrial\x20and\x20ventricular\x20activation.</li>\x0a<li>The\x20P\x20wave\x20may\x20sometimes\x20be\x20seen\x20at\x20the\x20end\x20of\x20the\x20QRS\x20complex\x20as\x20a\x20<strong>pseudo-r\x27\x20wave\x20(V1)</strong>&nbsp;(black\x20arrow)\x20and\x20<strong>pseudo-S\x20wave\x20(II,\x20III,\x20aVF)&nbsp;</strong>(blue\x20arrows).&nbsp;</li>\x0a</ul>\x0a</div>','explanation_video':'','question_images':[_0x291fca(0x315)],'explanation_images':[_0x291fca(0x24c),_0x291fca(0x226)]},{'text':_0x291fca(0x3ac),'choices':[{'id':0x1,'text':'Methimazole'},{'id':0x2,'text':_0x291fca(0x23e)},{'id':0x3,'text':'Radioactive\x20iodine'},{'id':0x4,'text':_0x291fca(0x123)}],'correct_choice_id':0x3,'solution':'<p><strong>Radioactive\x20iodine\x20therapy</strong>\x20is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.\x20Therefore,\x20it\x20is\x20not\x20a\x20treatment\x20option\x20in\x20this\x20patient.</p>\x0a<p>Thyrotoxicosis\x20in\x20pregnancy:</p>\x0a<p>The\x20<strong>drug\x20of\x20choice</strong>\x20for\x20the\x20treatment\x20of\x20thyrotoxicosis\x20during\x20the<strong>\x20first\x20trimester\x20</strong>of\x20pregnancy\x20is\x20<strong>propylthiouracil\x20(PTU).</strong></p>\x0a<p>Methimazole\x20and\x20its\x20prodrug\x20(carbimazole)\x20are\x20usually\x20avoided\x20in\x20the\x20first\x20trimester\x20due\x20to\x20<strong>teratogenic\x20risk.</strong>&nbsp;However,\x20methimazole\x20is\x20used\x20for\x20the\x20remainder\x20of\x20the\x20pregnancy\x20due\x20to\x20the\x20concern\x20for\x20<strong>PTU-associated\x20liver\x20failure.</strong>&nbsp;</p>\x0a<p><strong>Subtotal\x20thyroidectomy</strong>\x20can\x20be\x20performed\x20during\x20the\x20<strong>mid-trimester.</strong></p>\x0a<p><strong>Radioactive\x20iodine\x20</strong>crosses\x20the\x20placenta\x20and\x20causes\x20the\x20destruction\x20of\x20the\x20fetal\x20thyroid.\x20Therefore,\x20it&nbsp;is<strong>\x20contraindicated</strong>\x20during\x20pregnancy\x20and\x20lactation.</p>\x0a<p>Treatment\x20of\x20thyrotoxicosis\x20in\x20pregnancy</p>\x0a<table\x20style=\x22height:\x20108px;\x20width:\x20381px;\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x20text-align:\x20center;\x22><strong>Treatment\x20for\x20thyrotoxicosis</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2046px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2046px;\x22><strong>First\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2046px;\x22>\x0a<ul>\x0a<li>Propylthiouracil</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2064px;\x22>\x0a<td\x20style=\x22width:\x20137.828125px;\x20height:\x2064px;\x22><strong>Second\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x20height:\x2064px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a<li>Subtotal\x20thyroidectomy</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20137.828125px;\x22><strong>Third\x20trimester</strong></td>\x0a<td\x20style=\x22width:\x20227.1875px;\x22>\x0a<ul>\x0a<li>Methimazole</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x221),'choices':[{'id':0x1,'text':'Ranolazine'},{'id':0x2,'text':_0x291fca(0x1cc)},{'id':0x3,'text':'Trimetazidine'},{'id':0x4,'text':_0x291fca(0x351)}],'correct_choice_id':0x2,'solution':'<p>The\x20patient\x20was\x20likely\x20started\x20on<strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;ivabradine.&nbsp;</span></strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Ivabradine\x20may\x20be\x20used\x20in\x20chronic\x20heart\x20failure\x20patients\x20who</span><strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;do\x20not\x20tolerate\x20&beta;\x20blockers</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;or\x20have\x20a&nbsp;</span>heart\x20rate\x20of<strong><span\x20data-preserver-spaces=\x22true\x22>\x20&gt;75\x20</span></strong>beats/min\x20even\x20<strong>with<span\x20data-preserver-spaces=\x22true\x22>&nbsp;&beta;\x20blocker\x20</span></strong>administration<span\x20data-preserver-spaces=\x22true\x22>.\x20One\x20of\x20its\x20common\x20side\x20effects\x20includes\x20the\x20development\x20of\x20<strong>phosphenes</strong>.\x20Phosphenes\x20are\x20transiently\x20enhanced\x20brightness\x20in\x20specific\x20areas\x20of\x20the\x20visual\x20field.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Ivabradine\x20selectively\x20blocks\x20the\x20hyperpolarization-activated\x20sodium\x20channels\x20(HCN)\x20in\x20the\x20SA\x20node\x20to\x20reduce\x20the\x20pacemaker\x20current&nbsp;I<sub>f</sub>&nbsp;(Na<sup>+</sup>&nbsp;funny\x20current\x20channel)\x20and\x20<strong>decreases\x20heart\x20rate.\x20</strong>It</span><span\x20data-preserver-spaces=\x22true\x22>&nbsp;</span>reduces\x20heart\x20rate\x20without\x20affecting\x20myocardial\x20contractility,\x20ventricular\x20repolarization,\x20or\x20intracardiac\x20conduction.<span\x20data-preserver-spaces=\x22true\x22>&nbsp;The&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>antianginal\x20effect</span></strong><span\x20data-preserver-spaces=\x22true\x22>&nbsp;is\x20mainly\x20by\x20reducing\x20heart\x20rate\x20and\x20thereby\x20decreasing\x20the\x20O<sub>2</sub>\x20demand\x20of\x20the\x20myocardium.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Other\x20side\x20effects\x20include\x20bradycardia,\x20QT\x20prolongation,\x20and\x20atrial\x20fibrillation.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>The\x20hyperpolarization\x20cyclic\x20nucleotide\x20(HCN)\x20channels\x20are\x20also\x20present\x20on\x20the\x20retina.\x20These\x20channels\x20on\x20continuous\x20blockade\x20by\x20ivabradine\x20are&nbsp;</span><strong><span\x20data-preserver-spaces=\x22true\x22>hyperpolarized&nbsp;</span></strong>and\x20lead\x20to<strong><span\x20data-preserver-spaces=\x22true\x22>\x20increased\x20brightness\x20</span></strong>in\x20restricted\x20areas\x20of\x20the\x20visual\x20field.\x20These\x20phenomena\x20are\x20known\x20as<strong><span\x20data-preserver-spaces=\x22true\x22>\x20phosphenes.&nbsp;</span></strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Normally,\x20the\x20signal\x20transduction\x20pathway\x20in\x20the\x20retina\x20involves\x20the\x20opening\x20of\x20HCN\x20channels.\x20This\x20leads\x20to\x20the\x20influx\x20of\x20calcium\x20to\x20activate\x20cGMP\x20and\x20causes\x20recovery\x20from\x20light\x20to\x20dark.\x20In\x20cases\x20where\x20HCN\x20channels\x20are\x20blocked,\x20this\x20pathway\x20is\x20affected\x20and\x20recovery\x20from\x20light\x20to\x20dark\x20takes\x20time\x20resulting\x20in\x20increased\x20brightness.\x20The\x20image\x20attached\x20below\x20shows\x20a\x20normal\x20transduction\x20pathway.</span></p>','explanation_video':'','question_images':[],'explanation_images':[_0x291fca(0x2e1)]},{'text':_0x291fca(0x3b6),'choices':[{'id':0x1,'text':_0x291fca(0x257)},{'id':0x2,'text':'Bromocriptine'},{'id':0x3,'text':_0x291fca(0x261)},{'id':0x4,'text':'Ephedrine'}],'correct_choice_id':0x3,'solution':_0x291fca(0x35f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20with\x20chronic\x20pain\x20was\x20prescribed\x20a\x20drug\x20that\x20inhibits\x20the\x20reuptake\x20of\x20serotonin\x20and\x20norepinephrine.\x20Identify\x20the\x20prescribed\x20drug.','choices':[{'id':0x1,'text':_0x291fca(0x21d)},{'id':0x2,'text':_0x291fca(0x2a6)},{'id':0x3,'text':_0x291fca(0x2ac)},{'id':0x4,'text':_0x291fca(0x1fe)}],'correct_choice_id':0x2,'solution':'<p><strong>Tramadol\x20</strong>is\x20a\x20synthetic\x20codeine\x20analog<strong>.\x20</strong>Mechanism\x20of\x20action\x20is\x20a\x20combination\x20of\x20effects\x20as\x20mentioned\x20below-</p>\x0a<ul>\x0a<li>Weak\x20agonist\x20action\x20on\x20the\x20mu-opioid\x20receptor</li>\x0a<li><strong>Inhibition\x20of\x20serotonin\x20reuptake</strong>\x20transporter\x20(moderate\x20action)\x20and<strong>\x20norepinephrine\x20reuptake</strong>\x20transporter\x20(weak\x20action).&nbsp;</li>\x0a</ul>\x0a<p>It\x20is\x20used\x20to\x20induce\x20analgesia\x20for\x20moderate\x20pain\x20and\x20can\x20be\x20used\x20as\x20an\x20adjunct\x20to\x20opioid\x20therapy\x20in\x20chronic\x20pain\x20conditions.&nbsp;</p>\x0a<p>Other\x20options:&nbsp;They\x20do\x20not\x20affect\x20serotonin\x20and\x20norepinephrine\x20reuptake</p>\x0a<p>Option\x20A:<strong>\x20Hydromorphone&nbsp;</strong>is\x20a\x20phenanthrene\x20drug\x20with\x20<strong>strong\x20mu-opioid\x20agonist</strong>\x20action\x20with\x20a\x20variable\x20affinity\x20for\x20delta\x20and\x20kappa\x20receptors.\x20It\x20is\x20similar\x20to\x20morphine.&nbsp;&nbsp;</p>\x0a<p>Option\x20C:<strong>\x20Buprenorphine&nbsp;</strong>is\x20also\x20a\x20phenanthrene\x20derivative\x20that\x20has\x20<strong>mixed\x20opioid\x20agonist-antagonist</strong>\x20activity.\x20It\x20is\x20a\x20partial\x20mu-agonist\x20and\x20has\x20antagonist\x20activity\x20at\x20delta\x20and\x20kappa\x20receptors.\x20While\x20it\x20can\x20serve\x20as\x20an\x20analgesic,\x20it\x20antagonizes\x20the\x20action\x20of\x20strong\x20mu-agonists\x20such\x20as\x20morphine.\x20It\x20is\x20used\x20to\x20treat\x20moderate\x20pain\x20and\x20reduced\x20cravings\x20in\x20patients\x20recovering\x20from\x20alcoholism.</p>\x0a<p>Option\x20D:<strong>\x20Hydrocodone&nbsp;</strong>is\x20a\x20phenanthrene\x20drug\x20with&nbsp;<strong>mild-moderate\x20mu-opioid\x20agonist&nbsp;</strong>action.\x20It\x20is\x20less\x20efficacious\x20than\x20morphine.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x10e),'choices':[{'id':0x1,'text':'Zonisamide'},{'id':0x2,'text':_0x291fca(0x119)},{'id':0x3,'text':_0x291fca(0xf5)},{'id':0x4,'text':_0x291fca(0x12a)}],'correct_choice_id':0x2,'solution':_0x291fca(0x114),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x27a),'choices':[{'id':0x1,'text':_0x291fca(0x19d)},{'id':0x2,'text':_0x291fca(0x2c9)},{'id':0x3,'text':_0x291fca(0x24f)},{'id':0x4,'text':'Rifaximin'}],'correct_choice_id':0x1,'solution':_0x291fca(0x2cd),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Your\x20friend\x20is\x20planning\x20a\x20trip\x20to\x20the\x20mountains\x20but\x20is\x20concerned\x20because\x20of\x20her\x20history\x20of\x20severe\x20nausea\x20and\x20vomiting\x20while\x20traveling\x20anywhere.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20be\x20the\x20least\x20effective\x20in\x20managing\x20her\x20condition?','choices':[{'id':0x1,'text':_0x291fca(0x174)},{'id':0x2,'text':_0x291fca(0x387)},{'id':0x3,'text':_0x291fca(0x1fd)},{'id':0x4,'text':_0x291fca(0x1b3)}],'correct_choice_id':0x2,'solution':_0x291fca(0x2ba),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0xf8),'choices':[{'id':0x1,'text':_0x291fca(0x2b7)},{'id':0x2,'text':_0x291fca(0x321)},{'id':0x3,'text':_0x291fca(0x17d)},{'id':0x4,'text':_0x291fca(0x314)}],'correct_choice_id':0x2,'solution':_0x291fca(0x1a5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x2d0),'choices':[{'id':0x1,'text':'Decreases\x20incidence\x20of\x20hot\x20flashes'},{'id':0x2,'text':'Increases\x20incidence\x20of\x20endometrial\x20hyperplasia'},{'id':0x3,'text':_0x291fca(0x30d)},{'id':0x4,'text':_0x291fca(0x25e)}],'correct_choice_id':0x3,'solution':_0x291fca(0x111),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x39d),'choices':[{'id':0x1,'text':_0x291fca(0x14f)},{'id':0x2,'text':_0x291fca(0x15a)},{'id':0x3,'text':_0x291fca(0x1ce)},{'id':0x4,'text':'Alpha\x201'}],'correct_choice_id':0x1,'solution':_0x291fca(0x318),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x1e9),'choices':[{'id':0x1,'text':'Senna'},{'id':0x2,'text':_0x291fca(0x102)},{'id':0x3,'text':_0x291fca(0x1de)},{'id':0x4,'text':'Lactulose'}],'correct_choice_id':0x4,'solution':_0x291fca(0x1aa),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20one\x20of\x20the\x20following\x20conditions\x20requires\x20treatment\x20with\x20pulsatile\x20doses\x20of\x20GnRH\x20agonists?','choices':[{'id':0x1,'text':_0x291fca(0x19f)},{'id':0x2,'text':'Precocious\x20puberty'},{'id':0x3,'text':_0x291fca(0x320)},{'id':0x4,'text':_0x291fca(0x18d)}],'correct_choice_id':0x1,'solution':_0x291fca(0xf2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x291fca(0x20e),'choices':[{'id':0x1,'text':_0x291fca(0x357)},{'id':0x2,'text':'Rituximab+\x20Cyclophosphamide'},{'id':0x3,'text':'Bortezomib\x20+\x20Rituximab'},{'id':0x4,'text':'Lenalidomide\x20+\x20Bortezomib+Dexamethasone'}],'correct_choice_id':0x4,'solution':_0x291fca(0x38b),'explanation_video':'','question_images':[_0x291fca(0x287)],'explanation_images':[_0x291fca(0x24e)]},{'text':_0x291fca(0x188),'choices':[{'id':0x1,'text':_0x291fca(0x2b9)},{'id':0x2,'text':'1,\x203\x20&\x205'},{'id':0x3,'text':_0x291fca(0x362)},{'id':0x4,'text':_0x291fca(0x324)}],'correct_choice_id':0x2,'solution':_0x291fca(0x2ec),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/e78da2196a8f48dc97e5db27603061c7x1280x1794.JPEG']},{'text':'Arrange\x20the\x20following\x20insulin\x20preparations\x20in\x20ascending\x20order\x20of\x20their\x20respective\x20duration\x20of\x20action.','choices':[{'id':0x1,'text':'3-5-4-1-2'},{'id':0x2,'text':'4-2-5-3-1'},{'id':0x3,'text':'3-4-5-2-1'},{'id':0x4,'text':_0x291fca(0x37b)}],'correct_choice_id':0x3,'solution':'<p>The\u00a0insulin\x20preparations\x20in\x20<strong>ascending\x20order</strong>\x20of\x20their\x20respective\x20<strong>duration\x20of\x20action</strong>\x20are\x20as\x20follows:</p>\x0a<ol>\x0a<li>Afrezza</li>\x0a<li>Aspart</li>\x0a<li>Regular</li>\x0a<li>Glargine</li>\x0a<li>Degludec</li>\x0a</ol>\x0a<table\x20style=\x22height:\x20206px;\x22\x20width=\x22453\x22>\x0a<tbody>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\x0a<p\x20class=\x22p1\x22>Preparation</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\x0a<p\x20class=\x22p1\x22>Onset\x20(h)</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\x0a<p\x20class=\x22p1\x22>Peak\x20(h)</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22>\x0a<p\x20class=\x22p1\x22>Effective\x20Duration\x20(h)</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22\x20colspan=\x224\x22>Short-acting\u00a0\u00a0\u00a0</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x20132px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x20132px;\x22>\x0a<p>\u00a0</p>\x0a<ul>\x0a<li><strong>Aspart</strong></li>\x0a<li>Glulisine</li>\x0a<li>Lispro</li>\x0a</ul>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x20132px;\x22>\x0a<p\x20class=\x22p1\x22>&lt;0.25</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x20132px;\x22>\x0a<p\x20class=\x22p1\x22>0.5–1.5</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x20132px;\x22>\x0a<p\x20class=\x22p1\x22><strong>3–4</strong></p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2064px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2064px;\x22>\x0a<p><strong>Regular</strong></p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2064px;\x22>\x0a<p\x20class=\x22p1\x22>0.5–1.0</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2064px;\x22>\x0a<p\x20class=\x22p1\x22>2–3</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2064px;\x22>\x0a<p\x20class=\x22p1\x22><strong>4–6</strong></p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22\x20colspan=\x224\x22>Long-acting</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2031.5753px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2031.5753px;\x22>\x0a<p\x20class=\x22p1\x22>Detemir</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2067.5753px;\x22\x20rowspan=\x223\x22>\u00a0\x0a<p\x20class=\x22p1\x22>1–4</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2067.5753px;\x22\x20rowspan=\x223\x22>\u00a0Minimal\x20peak\x20activity\x20at\x20steady\x20state</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2031.5753px;\x22>\x0a<p\x20class=\x22p1\x22>12–20</p>\x0a</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22><strong>Glargine</strong></td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22><strong>\u00a012–24</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22><strong>Degludec</strong></td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22><strong>\u00a024–42</strong></td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>NPH</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\u00a01–2</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\u00a06–10</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22>\u00a010–16</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22\x20colspan=\x224\x22>Insulin\x20combinations</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\u00a0\x0a<p\x20class=\x22p1\x22>Mixture:</p>\x0a<p\x20class=\x22p1\x22>Short-acting\x20(25%–50%)\x20and\x20Long\x20acting\x20(50%–76%)</p>\x0a</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\u00a0&lt;0.25–1.0</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>\u00a0Depends\x20on\x20preparation</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22>\u00a0Up\x20to\x2010–16</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22\x20colspan=\x224\x22>Inhaled\x20insulin</td>\x0a</tr>\x0a<tr\x20style=\x22height:\x2018px;\x22>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22><strong>Afrezza</strong></td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>&lt;0.25</td>\x0a<td\x20style=\x22width:\x20106.499px;\x20height:\x2018px;\x22>0.5–1.5</td>\x0a<td\x20style=\x22width:\x20106.513px;\x20height:\x2018px;\x22><strong>2–3</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>\u00a0</p>\x0a<p>A\x20graphical\x20plot\x20of\x20various\x20preparations\x20of\x20insulin\x20vs\x20time\x20is\x20as\x20follows:</p>','explanation_video':'','question_images':[],'explanation_images':[_0x291fca(0x19b),'https://dhmbxeygs57ff.cloudfront.net/uploads/3600afa8b9b5452e9ec20f692fbf0ed7x1279x884.JPEG']},{'text':_0x291fca(0x30c),'choices':[{'id':0x1,'text':'Phosphodiesterase\x203\x20inhibitors'},{'id':0x2,'text':_0x291fca(0x2c0)},{'id':0x3,'text':_0x291fca(0x359)},{'id':0x4,'text':_0x291fca(0x2e5)}],'correct_choice_id':0x2,'solution':_0x291fca(0x126),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x291fca(0x2b3);const quizFilename='integrated-mini-test-12-pharmacology-18829aaf.html';let hierarchy=[_0x291fca(0x290),_0x291fca(0x32b),'2024-25'];if(window[_0x291fca(0x243)][_0x291fca(0x392)]['endsWith']('custom_quiz.html')){const customData=JSON[_0x291fca(0x26f)](localStorage[_0x291fca(0x273)](_0x291fca(0xf9)));if(customData){const NwTFbY=_0x291fca(0x310)['split']('|');let EcawLj=0x0;while(!![]){switch(NwTFbY[EcawLj++]){case'0':hierarchy=customData[_0x291fca(0x301)];continue;case'1':quizName=customData[_0x291fca(0x1ca)];continue;case'2':document['title']=quizName+_0x291fca(0x2f7);continue;case'3':document['getElementById'](_0x291fca(0x191))['textContent']=hierarchy[_0x291fca(0x150)](_0x291fca(0x3b2));continue;case'4':questionsData=customData[_0x291fca(0x118)];continue;case'5':document[_0x291fca(0x2fd)](_0x291fca(0x1ac))[_0x291fca(0x2a9)]=questionsData[_0x291fca(0x1eb)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x291fca(0x393),timer=null,timeRemaining=0x0,questionStartTime=Date['now'](),quizStartTime=Date[_0x291fca(0x1f2)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x291fca(0x1eb)])[_0x291fca(0x3ab)](null)[_0x291fca(0x27d)](()=>({'status':_0x291fca(0x1d0),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x125272=_0x291fca,_0x7454c={'bUOYF':_0x125272(0x288)};if(isQuizCompleted)return;const _0x360554=JSON[_0x125272(0x26f)](localStorage['getItem'](_0x125272(0x1d9)))||{};_0x360554[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x7454c[_0x125272(0x280)],'lastSeen':new Date()['toISOString']()},localStorage[_0x125272(0x22c)](_0x125272(0x1d9),JSON[_0x125272(0x34b)](_0x360554));}function loadProgress(){const _0x50d526=_0x291fca,_0x5966f4={'gdEUA':function(_0x514746,_0x4474d6){return _0x514746/_0x4474d6;},'dfmZy':function(_0x535256,_0x54e945){return _0x535256%_0x54e945;},'oqVKS':function(_0xafa11e,_0x35b39f){return _0xafa11e+_0x35b39f;},'nuBzH':function(_0xdaf964,_0x650aa1){return _0xdaf964!==_0x650aa1;},'CQVXU':_0x50d526(0x378),'UkNFa':_0x50d526(0x2ca),'eIIkj':_0x50d526(0x103)},_0x1a1374=JSON[_0x50d526(0x26f)](localStorage[_0x50d526(0x273)]('userHistory'))||{},_0x178f3=_0x1a1374[quizFilename];if(_0x178f3){if(_0x5966f4[_0x50d526(0xee)](_0x5966f4[_0x50d526(0x184)],_0x5966f4[_0x50d526(0x184)])){const _0x248c7d=_0x2ffb23[_0x50d526(0x1d3)](_0x5966f4[_0x50d526(0x151)](_0x26c0f5,0x3c)),_0x227d65=_0x5966f4['dfmZy'](_0x16a39c,0x3c);_0x33f685[_0x50d526(0x2fd)](_0x50d526(0x274))['textContent']=_0x5966f4[_0x50d526(0x374)](_0x5966f4[_0x50d526(0x374)](_0x248c7d,':'),_0x227d65['toString']()[_0x50d526(0x1b5)](0x2,'0'));}else{const _0x37103f=_0x5966f4[_0x50d526(0x1b4)][_0x50d526(0x29f)]('|');let _0x2bc232=0x0;while(!![]){switch(_0x37103f[_0x2bc232++]){case'0':console['log'](_0x5966f4[_0x50d526(0x28e)]);continue;case'1':currentMode=_0x178f3['currentMode'];continue;case'2':stats=_0x178f3[_0x50d526(0x1e5)];continue;case'3':return!![];case'4':questionStates=_0x178f3['questionStates'];continue;case'5':currentQuestionIndex=_0x178f3[_0x50d526(0x16c)];continue;}break;}}}return![];}function clearProgress(){const _0x3f0fc9=_0x291fca,_0x1a0175={'kCJxl':_0x3f0fc9(0x1d9)},_0x1cc217=JSON[_0x3f0fc9(0x26f)](localStorage[_0x3f0fc9(0x273)]('userHistory'))||{};_0x1cc217[quizFilename]&&(delete _0x1cc217[quizFilename],localStorage[_0x3f0fc9(0x22c)](_0x1a0175[_0x3f0fc9(0x345)],JSON[_0x3f0fc9(0x34b)](_0x1cc217)),console[_0x3f0fc9(0x384)](_0x3f0fc9(0x336)));}function markQuizAsCompleted(){const _0x1bca55=_0x291fca,_0x50b226={'rDnbB':'completed','TwbPq':_0x1bca55(0x1d9)},_0x1aa532=JSON[_0x1bca55(0x26f)](localStorage[_0x1bca55(0x273)](_0x1bca55(0x1d9)))||{},_0x4041ba=questionsData[_0x1bca55(0x1eb)],_0x2ae8d1=stats[_0x1bca55(0x30e)]||0x0;_0x1aa532[quizFilename]={'score':_0x2ae8d1,'total':_0x4041ba,'status':_0x50b226['rDnbB'],'completedOn':new Date()[_0x1bca55(0x2e6)]()},localStorage[_0x1bca55(0x22c)](_0x50b226[_0x1bca55(0x2c5)],JSON[_0x1bca55(0x34b)](_0x1aa532));}const urlParams=new URLSearchParams(window[_0x291fca(0x243)]['search']),startAt=parseInt(urlParams[_0x291fca(0x259)](_0x291fca(0x2ad))),resume=urlParams[_0x291fca(0x259)](_0x291fca(0x1b1))===_0x291fca(0x1a1);function goBack(){const _0x381021=_0x291fca,_0x20e013={'gGMcV':function(_0x4c7c7c){return _0x4c7c7c();},'QWrEG':_0x381021(0x272)};if(!isQuizCompleted)_0x20e013[_0x381021(0x1f3)](saveProgress);window[_0x381021(0x243)][_0x381021(0x26d)]=document[_0x381021(0x322)]||_0x20e013[_0x381021(0x110)];}function selectMode(_0x45961d){const _0x5549b2=_0x291fca,_0xa726f7={'KxYHo':_0x5549b2(0x2d3),'rhYRy':function(_0x21cd6f){return _0x21cd6f();}};currentMode=_0x45961d,document[_0x5549b2(0x2fd)]('modeModal')[_0x5549b2(0x173)]['display']=_0xa726f7[_0x5549b2(0x2ff)],_0xa726f7[_0x5549b2(0x121)](initializeQuiz);}function initializeQuiz(){const _0x4f0856=_0x291fca,_0x5a96ae={'ozWby':function(_0x51a2ae,_0x4eda2f){return _0x51a2ae(_0x4eda2f);},'CvmPT':function(_0x3941d2,_0x3a67ff){return _0x3941d2+_0x3a67ff;},'QOIFY':'return\x20(function()\x20','kKMxj':_0x4f0856(0x241),'hGOki':'bookmarkBtn','Jrzwi':_0x4f0856(0x332),'mTYHz':_0x4f0856(0x3b8),'FLaoC':function(_0x3a35c7,_0xab2f32){return _0x3a35c7===_0xab2f32;},'jmBJG':_0x4f0856(0x3af),'uRpbS':function(_0x11e2e2,_0x3af066){return _0x11e2e2===_0x3af066;},'Ydess':'timed_exam','INRZf':_0x4f0856(0x120),'agkiN':_0x4f0856(0x207),'eyIrs':'none','jTvlm':_0x4f0856(0x2c7),'plRuu':_0x4f0856(0x238),'qFyQo':'submitSection','hhLfP':_0x4f0856(0x292),'EBmrP':'timed_study','FTjwb':function(_0x11d3d7,_0x25728f){return _0x11d3d7===_0x25728f;},'yAMez':_0x4f0856(0x1e4),'bZmYC':_0x4f0856(0x113),'ZzOXB':function(_0x2c966f,_0x158d18){return _0x2c966f<_0x158d18;},'Vmtdb':_0x4f0856(0x230),'DaSZx':function(_0x2e626f){return _0x2e626f();},'Vfdva':function(_0x3bd6ac){return _0x3bd6ac();}};quizStartTime=Date[_0x4f0856(0x1f2)]();const _0x43effa=document['getElementById'](_0x5a96ae[_0x4f0856(0x27f)]),_0x4b15b7=document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x36b)]),_0x5ce240=document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x249)]),_0x3a8a1f=_0x5a96ae[_0x4f0856(0x2d2)](currentMode,_0x5a96ae[_0x4f0856(0x294)])||_0x5a96ae['uRpbS'](currentMode,_0x5a96ae[_0x4f0856(0x326)]);document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x278)])[_0x4f0856(0x173)][_0x4f0856(0x2d8)]=_0x3a8a1f?_0x4f0856(0x2d3):_0x4f0856(0x2c7),document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x32e)])[_0x4f0856(0x173)]['display']=_0x3a8a1f?_0x5a96ae[_0x4f0856(0x38c)]:_0x5a96ae[_0x4f0856(0x289)],document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x38f)])[_0x4f0856(0x173)][_0x4f0856(0x2d8)]=_0x3a8a1f?_0x5a96ae[_0x4f0856(0x289)]:_0x4f0856(0x2d3),document['getElementById'](_0x5a96ae[_0x4f0856(0x18c)])['style']['display']=_0x3a8a1f?_0x5a96ae[_0x4f0856(0x289)]:_0x4f0856(0x2d3),_0x43effa[_0x4f0856(0x173)][_0x4f0856(0x2d8)]=_0x3a8a1f?_0x5a96ae['eyIrs']:_0x5a96ae[_0x4f0856(0x39a)],_0x4b15b7[_0x4f0856(0x173)][_0x4f0856(0x2d8)]=_0x3a8a1f?_0x4f0856(0x292):_0x4f0856(0x2d3),_0x5ce240[_0x4f0856(0x173)][_0x4f0856(0x2d8)]=_0x3a8a1f?_0x5a96ae[_0x4f0856(0x39a)]:_0x5a96ae[_0x4f0856(0x38c)];(_0x5a96ae[_0x4f0856(0x2d2)](currentMode,_0x5a96ae['EBmrP'])||_0x5a96ae[_0x4f0856(0x383)](currentMode,_0x5a96ae[_0x4f0856(0x326)]))&&document[_0x4f0856(0x2fd)](_0x5a96ae[_0x4f0856(0x12b)])[_0x4f0856(0x365)][_0x4f0856(0x158)](_0x5a96ae[_0x4f0856(0x170)]);if(!_0x5a96ae[_0x4f0856(0x21a)](isNaN,startAt)&&startAt>=0x0&&_0x5a96ae['ZzOXB'](startAt,questionsData[_0x4f0856(0x1eb)])){if(_0x5a96ae[_0x4f0856(0x183)]==='NBYFc'){let _0x19d1f1;try{_0x19d1f1=gqkBQV[_0x4f0856(0x21a)](_0x44fc24,gqkBQV['CvmPT'](gqkBQV[_0x4f0856(0x2a7)](gqkBQV[_0x4f0856(0x30b)],gqkBQV[_0x4f0856(0x1c4)]),');'))();}catch(_0x231220){_0x19d1f1=_0x3434ed;}return _0x19d1f1;}else currentQuestionIndex=startAt;}_0x5a96ae[_0x4f0856(0x1be)](loadBookmarkedQuestions),generateQuestionNav(),updateStats(),_0x5a96ae[_0x4f0856(0x2cc)](displayQuestion);}function generateQuestionNav(){const _0x1fff8b=_0x291fca,_0x1fed8e={'puMiP':function(_0x22de9e,_0x36baae){return _0x22de9e<_0x36baae;},'VrkUr':'button','flTQO':_0x1fff8b(0x38e),'QyfZy':function(_0x68ba8a){return _0x68ba8a();}},_0x360cb1=document[_0x1fff8b(0x2fd)](_0x1fff8b(0x325));_0x360cb1[_0x1fff8b(0x160)]='';for(let _0x5223b5=0x0;_0x1fed8e[_0x1fff8b(0x29c)](_0x5223b5,questionsData[_0x1fff8b(0x1eb)]);_0x5223b5++){const _0x1b9c5b=document['createElement'](_0x1fed8e[_0x1fff8b(0x13c)]);_0x1b9c5b[_0x1fff8b(0x2a9)]=_0x5223b5+0x1,_0x1b9c5b['className']=_0x1fed8e[_0x1fff8b(0x240)],_0x1b9c5b[_0x1fff8b(0x31c)]=()=>jumpToQuestion(_0x5223b5),_0x1b9c5b['id']=_0x1fff8b(0x302)+_0x5223b5,_0x360cb1['appendChild'](_0x1b9c5b);}_0x1fed8e[_0x1fff8b(0x37f)](updateQuestionNav);}function updateQuestionNav(){const _0x4d02a6=_0x291fca,_0x25fd0c={'bbwyV':_0x4d02a6(0x1d9),'soqxH':'Previous\x20progress\x20cleared.','yQAoZ':function(_0x1f6613,_0x56f522){return _0x1f6613-_0x56f522;},'rpjGF':function(_0x1362aa,_0x398397){return _0x1362aa(_0x398397);},'qWPvF':_0x4d02a6(0x1ec),'fekdA':function(_0x3c2588,_0x4758d4){return _0x3c2588<_0x4758d4;},'lWfiF':function(_0x4c72bb,_0x5ea9a4){return _0x4c72bb===_0x5ea9a4;},'FRKwx':'GtfUv','TMrpo':_0x4d02a6(0x101),'BIYVf':'nav-btn-bookmarked','cMjpU':function(_0x32a33b,_0x9d097b){return _0x32a33b!==_0x9d097b;},'aEYtM':_0x4d02a6(0x1cd),'aCpQi':_0x4d02a6(0x39c),'aafjs':'study','oeYDo':function(_0x58cda0,_0x2baa62){return _0x58cda0===_0x2baa62;},'ltioM':function(_0x12c73e,_0x52cbde){return _0x12c73e!==_0x52cbde;},'cTyqy':_0x4d02a6(0x331),'cMLkl':_0x4d02a6(0x12c),'qdibg':function(_0x33a16f,_0x58a88e){return _0x33a16f===_0x58a88e;},'pEkZc':'nav-btn-incorrect','OYuOe':_0x4d02a6(0x300),'jXBPk':function(_0x1f09f7,_0x50f9d5){return _0x1f09f7!==_0x50f9d5;},'LeFYm':'nav-btn-answered'};for(let _0xd255ac=0x0;_0xd255ac<questionsData['length'];_0xd255ac++){if(_0x25fd0c[_0x4d02a6(0x252)](_0x25fd0c[_0x4d02a6(0x305)],_0x4d02a6(0x1c5))){const _0x526d28=_0x459b1d['parse'](_0x2d76b1[_0x4d02a6(0x273)](_0x25fd0c['bbwyV']))||{};_0x526d28[_0x37ef78]&&(delete _0x526d28[_0x316cbf],_0x240d37[_0x4d02a6(0x22c)](_0x4d02a6(0x1d9),_0x4fafb8[_0x4d02a6(0x34b)](_0x526d28)),_0x5a787d[_0x4d02a6(0x384)](_0x25fd0c[_0x4d02a6(0x17b)]));}else{const _0x324bcc=document[_0x4d02a6(0x2fd)](_0x4d02a6(0x302)+_0xd255ac),_0x44bc6a=questionStates[_0xd255ac];let _0x17e144='';if(_0x25fd0c[_0x4d02a6(0x252)](_0xd255ac,currentQuestionIndex))_0x17e144=_0x25fd0c[_0x4d02a6(0x36e)];else{if(_0x44bc6a[_0x4d02a6(0x14d)])_0x17e144=_0x25fd0c[_0x4d02a6(0x2cb)];else{if(_0x44bc6a[_0x4d02a6(0x330)]){if(_0x25fd0c[_0x4d02a6(0x1f6)](_0x25fd0c[_0x4d02a6(0x317)],_0x4d02a6(0x1cd))){const _0x4de193=_0x25fd0c[_0x4d02a6(0x369)](_0x25fd0c[_0x4d02a6(0x260)](_0x45b6c1,_0x22fdf8[_0x4d02a6(0x28c)]),0x1),_0x3aab28=_0x16170f[_0x4d02a6(0xf4)](_0x25fd0c[_0x4d02a6(0x2f9)]);if(_0x25fd0c[_0x4d02a6(0x218)](_0x4de193,_0x3aab28[_0x4d02a6(0x1eb)]))_0x25fd0c[_0x4d02a6(0x260)](_0x27bc8c,_0x4de193);}else _0x17e144=_0x25fd0c[_0x4d02a6(0x2b6)];}else{if(_0x25fd0c[_0x4d02a6(0x252)](currentMode,_0x25fd0c['aafjs'])||_0x25fd0c[_0x4d02a6(0x124)](currentMode,'timed_study')){if(_0x25fd0c[_0x4d02a6(0x25b)](_0x25fd0c[_0x4d02a6(0x395)],_0x4d02a6(0x331)))_0x381a85[_0x2c046a][_0x4d02a6(0x2aa)]+=_0x1c02fa[_0x4d02a6(0x1f2)]()-_0x2f8716;else{if(_0x44bc6a[_0x4d02a6(0x286)]===_0x4d02a6(0x24b))_0x17e144=_0x25fd0c['cMLkl'];else{if(_0x25fd0c[_0x4d02a6(0x215)](_0x44bc6a[_0x4d02a6(0x286)],'incorrect'))_0x17e144=_0x25fd0c['pEkZc'];else _0x17e144=_0x25fd0c[_0x4d02a6(0x36d)];}}}else{if(_0x25fd0c[_0x4d02a6(0x23d)](_0x44bc6a[_0x4d02a6(0x116)],null))_0x17e144=_0x25fd0c['LeFYm'];else _0x17e144=_0x25fd0c[_0x4d02a6(0x36d)];}}}}_0x324bcc[_0x4d02a6(0x28d)]=_0x4d02a6(0x2b1)+_0x17e144;}}}function _0x2504(){const _0x4c1de4=['ytpkx','oTblt','fekdA','sYCMA','ozWby','ujETQ','QybnV','Hydromorphone','aaVJb','modeModal','question_audio','A\x2064-year-old\x20male\x20is\x20diagnosed\x20with\x20chronic\x20congestive\x20heart\x20failure\x20and\x20is\x20started\x20on\x20beta-blockers.\x20His\x20symptoms\x20fail\x20to\x20improve,\x20and\x20he\x20is\x20started\x20on\x20a\x20new\x20drug.\x20His\x20BP\x20is\x20132/80\x20mmHg,\x20and\x20his\x20heart\x20rate\x20is\x2084\x20beats/minute.\x20He\x20now\x20complains\x20of\x20visual\x20disturbances\x20characterized\x20by\x20a\x20transiently\x20enhanced\x20brightness\x20in\x20particular\x20areas\x20of\x20the\x20visual\x20field.\x20What\x20is\x20the\x20drug\x20he\x20was\x20likely\x20to\x20have\x20been\x20started\x20on?','AfkgL','correctResult','wFVSS','border-red-500','https://dhmbxeygs57ff.cloudfront.net/uploads/73866a11df3b4cba923658ca97b6c962x510x812.PNG','video[data-src]','div','bind','xLZIv','dzONm','setItem','DkLXs','chFKA','HNqPn','ukNlv','replace','seobt','mnDQZ','lyCsR','Digoxin','XngVk','haTol','testModeLegend','OHdBa','3321116RYzhUy','https://dhmbxeygs57ff.cloudfront.net/uploads/a67fb430face4bcd855de9119d4db775x360x98.JPEG','gRDFL','jXBPk','Propylthiouracil','question_images','flTQO','{}.constructor(\x22return\x20this\x22)(\x20)','add','location','oOzhf','<p>The\x20given\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20orbital\x20fat\x20atrophy\x20and\x20it\x20is\x20seen\x20with&nbsp;<strong>topical\x20PGF2&alpha;\x20(prostaglandin)\x20analogs&nbsp;</strong>like<strong>&nbsp;latanoprost.</strong></p>\x0a<p>Topical\x20PGF2\x20alpha\x20(prostaglandin)\x20analogs\x20are\x20used\x20as\x20a\x20first\x20line\x20in\x20glaucoma.&nbsp;<strong>Latanoprost</strong>&nbsp;is\x20the<strong>&nbsp;most&nbsp;commonly</strong>&nbsp;used\x20anti-glaucoma\x20medication.\x20Other\x20prostaglandin\x20analogues\x20are\x20travoprost,\x20bimatoprost,\x20tafluprost,\x20and\x20unoprostone.</p>\x0a<p>Mechanism\x20of\x20action:\x20It&nbsp;<strong>reduces\x20intraocular\x20pressure</strong>&nbsp;by\x20altering\x20the\x20ciliary\x20muscle\x20tension\x20and\x20improving\x20the&nbsp;<strong>outflow</strong>&nbsp;of\x20the\x20aqueous\x20humor.</p>\x0a<p>Adverse\x20effects:</p>\x0a<ul>\x0a<li>Blurring\x20of\x20vision</li>\x0a<li>Iris\x20pigmentation</li>\x0a<li>Thickening\x20and\x20darkening\x20of\x20eyelashes</li>\x0a<li>Macular\x20edema&nbsp;especially\x20in\x20aphakic\x20patients.&nbsp;</li>\x0a<li><strong>Orbital\x20fat\x20atrophy</strong></li>\x0a</ul>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A:<strong>\x20Timolol</strong>&nbsp;is\x20a&nbsp;<strong>non-selective\x20beta-blocker</strong>&nbsp;used\x20topically\x20in\x20glaucoma.\x20Ocular\x20adverse\x20effects\x20of\x20beta-blockers\x20include&nbsp;<strong>dryness</strong>&nbsp;and&nbsp;<strong>redness</strong>&nbsp;of\x20the\x20eye,\x20stinging,\x20corneal\x20hypoesthesia,\x20blurred\x20vision,\x20and\x20allergic\x20blepharoconjunctivitis.\x20Systemic\x20side\x20effects\x20like\x20bradycardia\x20and\x20bronchospasm\x20may\x20be\x20seen\x20due\x20to\x20absorption\x20through\x20the\x20nasolacrimal\x20duct.</p>\x0a<p>Option\x20B:\x20<strong>Pilocarpine</strong>&nbsp;is\x20a&nbsp;<strong>miotic</strong>&nbsp;agent\x20and\x20adverse\x20effects\x20are\x20corneal\x20edema,\x20miosis,\x20induced\x20myopia,\x20and\x20retinal\x20detachment.</p>\x0a<p>Option\x20C:<strong>\x20Acetazolamide</strong>&nbsp;is\x20a&nbsp;<strong>carbonic\x20anhydrase\x20inhibitor&nbsp;</strong>and\x20reduces\x20intraocular\x20pressure\x20by&nbsp;<strong>reducing&nbsp;</strong>the<strong>&nbsp;aqueous\x20humor\x20formation.&nbsp;</strong>It&nbsp;is\x20given\x20orally\x20and\x20the\x20systemic\x20adverse\x20effects\x20are\x20anorexia,\x20paresthesia,\x20hypokalemia,\x20acidosis,\x20and\x20depression.</p>','hRnVd','hikXP','pIZdc','mTYHz','ocPnc','correct','https://dhmbxeygs57ff.cloudfront.net/uploads/1124ef0817754554a5b835c82e1377d2x1280x644.JPEG','red','https://dhmbxeygs57ff.cloudfront.net/uploads/e607b9cda8ba4e52913d9b4df17e2270x1280x2516.JPEG','Alosetron','wTjoT','PTcgl','lWfiF','sjUIW','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','RlyRP','XiixB','Sumatriptan','jBaXg','get','zQZqt','ltioM','zzPvm','bgWUl','Increases\x20incidence\x20of\x20breast\x20carcinoma','JVkQf','rpjGF','Nitroprusside','MAROY','Mark\x20for\x20Review','kGFOB','search','InCOK','IhfOV','ZEvra','LakgI','CeCab','vWciz','jCFhX','href','Vabcd','parse','eLWVu','BEXcD','index.html','getItem','timeDisplay','(((.+)+)+)+$','bizdO','KNGaF','INRZf','NCBuz','A\x2033-year-old\x20female\x20patient\x20comes\x20to\x20your\x20clinic\x20with\x20crampy\x20abdominal\x20pain,\x20constipation,\x20and\x20bloating\x20on\x20and\x20off\x20for\x20the\x20past\x2010\x20years.\x20Pain\x20occurs\x20frequently\x20after\x20meals\x20and\x20is\x20relieved\x20after\x20defecation\x20without\x20any\x20bleeding\x20while\x20defecating.\x20On\x20examination,\x20the\x20abdomen\x20is\x20soft\x20and\x20non-tender.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20the\x20most\x20appropriate\x20management\x20for\x20this\x20patient\x27s\x20condition?','hPSKi','appendChild','map','lDGID','hGOki','bUOYF','pDVsY','sloVx','iZAGM','gVfdW','ClMjy','status','https://cdn1.dailyrounds.org/uploads/349c22547afe4047b9d2175715221f38.JPEG','incomplete','jTvlm','qfglO','pop','key','className','eIIkj','data-option-index','Marrow','GjTRA','flex','OAEhP','jmBJG','3776IIzqnJ','xvoHk','RrXWc','yDrdm','HmPvW','sJAWC','oMaSl','puMiP','round','yrCnF','split','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','sqCBi','constructor','XJDEr','cZGsS','timed_study','Tramadol','CvmPT','exception','textContent','timeSpent','Adenosine','Buprenorphine','startAt','selected','39673040qjqMFI','zmPdp','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','BFKVw','Integrated\x20Mini\x20Test\x2012\x20-\x20Pharmacology','JErJN','kGmnn','aCpQi','Agonistic\x20action\x20on\x20serotonin\x205HT4\x20receptor','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','1,\x202,\x203\x20&\x205','<p>Among\x20the\x20given\x20options,\x20ondansetron\x20is\x20the\x20least\x20effective\u00a0in\x20managing\x20motion\x20sickness.</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Ondansetron\x20is\x20a</span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a05\x20HT<sub>3</sub>\x20receptor\x20antagonist</span></strong>.\x20It\x20blocks\x20impulses\x20at\x20the\x20peripheral\x20origin\x20in\x20GIT\x20and\x20does\x20not\x20suppress\x20vomiting\x20caused\x20by\x20motion\x20sickness.\u00a0<span\x20data-preserver-spaces=\x22true\x22>It\x20is\x20most\x20commonly\x20indicated\x20for\x20the\x20treatment\x20of\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>postoperative\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>and\x20<strong>chemotherapy</strong>-<strong>induced</strong></span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0nausea\x20</span></strong>and\x20<strong><span\x20data-preserver-spaces=\x22true\x22>vomiting.\u00a0</span></strong></p>\x0a<p>Drugs\x20used\x20in\x20the\x20treatment\x20of\x20motion\x20sickness\x20are:</p>\x0a<ul>\x0a<li><strong><span\x20data-preserver-spaces=\x22true\x22>Anticholinergic</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0agents\x20(muscarinic\x20receptor\x20antagonists)\x20such\x20as\u00a0<strong>scopolamine</strong>\x20(<strong>hyoscine</strong>)\x20and\x20dicyclomine.</span></li>\x0a<li><strong><span\x20data-preserver-spaces=\x22true\x22>Antihistamines</span></strong>\x20(H1\x20antagonists)<strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>are\x20primarily\x20used\x20for\x20treating\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>motion\x20sickness\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>and</span><strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0postoperative\x20emesis.\u00a0\u00a0</span></strong></li>\x0a</ul>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong><span\x20data-preserver-spaces=\x22true\x22>Scopolamine\x20transdermal\x20patches\u00a0</span></strong><span\x20data-preserver-spaces=\x22true\x22>should\x20be\x20given\u00a0<strong>prophylactically</strong>\u00a0as\x20it\x20is\x20less\x20effective\x20once\x20symptoms\x20start.\x20It\x20is\u00a0<strong>applied\x20behind\x20the\x20ear</strong>\u00a0at\x20least\u00a0<strong>4-12</strong>\u00a0<strong>hours\x20before</strong>\u00a0an\x20anticipated\x20exposure\x20to\x20motion.\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>Dry</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>mouth\u00a0</span></strong>and<strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0sedation</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0are\x20common\x20side\x20effects.</span></span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>First-generation\x20antihistamines\x20such\x20as\x20<strong>promethazine,</strong>\x20dimenhydrinate,\x20chlorpheniramine,\x20<strong>diphenhydramine</strong>,\x20cyclizine,\x20and\x20<strong>meclizine</strong>\x20are\x20effective\x20in\x20controlling\x20nausea\x20and\x20vomiting\x20in\x20motion\x20sickness.\u00a0</span><strong><span\x20data-preserver-spaces=\x22true\x22>Sedation</span></strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0is\x20a\x20common\x20side\x20effect\x20of\x20these\x20drugs.\x20Second-generation\x20antihistamines\x20like\x20cetirizine\x20and\x20fexofenadine\x20are\x20ineffective\x20in\x20the\x20treatment\x20of\x20motion\x20sickness.</span></p>','mjirV','VInzK','ZYROd','avgTimeResult','questionText','Phosphodiesterase\x205\x20inhibitors','eWkcf','src','border-gray-600','Vinblastine','TwbPq','attachMedia','block','</span></div>','Loperamide','4|2|5|1|0|3','BIYVf','Vfdva','<p>This\x20patient\x27s\x20condition\x20is\x20irritable\x20bowel\x20syndrome\x20with\x20constipation\x20and\x20the\x20drug\x20used\x20for\x20this\x20condition\x20is\x20<strong>lubiprostone.</strong></p>\x0a<p>The\x20<strong>ROME\x20IV\x20criteria</strong>\u00a0is\u00a0used\x20to\x20diagnose<strong>\x20irritable\x20bowel\x20syndrome</strong>,\x20which\x20requires\x20at\x20least\x203\x20days\x20a\x20month\x20in\x20the\x20last\x203\x20months\x20associated\x20with\x202\x20or\x20more\x20of\u00a0the\x20following:</p>\x0a<ul>\x0a<li>improvement\x20in\x20abdominal\x20pain\x20or\x20discomfort\x20with\x20defecation</li>\x0a<li>onset\x20associated\x20with\x20a\x20change\x20in\x20frequency\x20of\x20stool</li>\x0a<li>and/or\x20an\x20onset\x20accompanied\x20by\x20a\x20change\x20in\x20form\x20or\x20appearance\x20of\x20stool</li>\x0a</ul>\x0a<p>It\x20is\u00a0approved\x20for<strong>\x20chronic\x20idiopathic\x20constipation\x20</strong>and<strong>\x20constipation-predominant\x20irritable\x20bowel\x20syndrome</strong>\x20(in\x20female\x20patients\x20&gt;18\x20years).\x20It\x20acts\x20by\x20stimulating\x20the\x20Cl-channels\x20opening\x20in\x20the\x20intestine\x20and\x20increasing\x20liquid\x20secretion\x20in\x20the\x20gut.\x20This\x20decreases\x20the\x20transit\x20time.</p>\x0a<p>Other\x20options:</p>\x0a<p>Alosetron\x20is\x20a\x205-HT3\x20receptor\x20antagonist\x20which\x20is\x20indicated\x20only\x20for\x20women\x20with\x20severe\x20diarrhea-predominant\x20IBS\x20who\x20have\x20chronic\x20IBS\x20symptoms\x20(\x20lasting\x206\x20months\x20or\x20longer)\x20and\x20have\x20not\x20responded\x20adequately\x20to\x20conventional\x20therapy.\x20Serious\x20GI\x20adverse\x20reactions\x20like\x20ischemic\x20colitis,\x20serious\x20complications\x20of\x20constipation\x20have\x20been\x20associated\x20with\x20its\x20usage.</p>\x0a<p>Rifaximin\x20is\x20indicated\x20for\x20irritable\x20bowel\x20syndrome\x20with\x20diarrhea\x20(IBS-D)\x20in\x20adult\x20men\x20and\x20women.</p>','custom_quiz.html','Latanoprost','A\x2055-year-old\x20post-menopausal\x20woman\x20with\x20a\x20family\x20history\x20of\x20breast\x20cancer\x20presents\x20with\x20persistent\x20lower\x20backache.\x20Her\x20bone\x20mineral\x20density\x20is\x20measured,\x20and\x20the\x20T-score\x20is\x20-2.6.\x20She\x20is\x20prescribed\x20raloxifene.\x20Which\x20of\x20the\x20following\x20effects\x20of\x20this\x20drug\x20should\x20the\x20patient\x20be\x20informed\x20about?','qnGIh','FLaoC','none','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','eGSXm','DkiZm','nQyXv','display','CDwbO','totalQuestionsResult','Uzfnm','10763406nwYLYa','aUGRa','vliZj','wXFfP','viWJi','https://dhmbxeygs57ff.cloudfront.net/uploads/a50eb5d73a8541fea55a3ea5b54bb2ffx1280x541.PNG','.m3u8','ZMLmw','kyugJ','Phosphodiesterase\x204\x20inhibitors','toISOString','tqRGD','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','3209520vGfPwT','fiQtW','incorrectAnswers','<p>The\x20drugs\x20used\x20for\x20pulmonary\x20hypertension\x20if\x20vasoreactivity\x20test\x20is\x20negative\x20are<strong>\x201,\x203,\x20and\x205.</strong></p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x2095\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p><strong>Bosentan</strong>\x20is\x20an\x20<strong>endothelin\x20receptor\x20antagonist,\x20sildenafil</strong>\x20is\x20a\x20<strong>phosphodiesterase-5\x20(PDE5)\x20inhibitor,</strong>\x20and\x20<strong>riociguat&nbsp;</strong>is\x20a\x20<strong>soluble\x20guanylyl\x20cyclase\x20stimulator&nbsp;</strong>used\x20to\x20treat\x20pulmonary\x20arterial\x20hypertension</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p><strong>Vasoreactivity\x20testing</strong>\x20involves\x20the\x20administration\x20of\x20inhaled\x20nitric\x20oxide,\x20IV\x20epoprostenol,\x20or\x20adenosine.&nbsp;The<strong>&nbsp;</strong>test\x20is\x20considered<strong>\x20positive</strong>\x20if\x20the\x20mean\x20pulmonary\x20arterial\x20pressure\x20(mPAH)<strong>\x20decreases.</strong></p>\x0a<ul>\x0a<li><strong>Positive\x20vasoreactivity\x20</strong>test:&nbsp;<strong>Calcium\x20channel\x20blockers&nbsp;</strong>(CCB)\x20are\x20indicated.\x20Nifedipine,\x20diltiazem\x20or\x20<strong>amlodipine</strong>\x20are\x20used.</li>\x0a<li><strong>Negative\x20vasoreactivity</strong>\x20test:\x20Drugs\x20other\x20than\x20CCBs\x20are\x20used.</li>\x0a</ul>\x0a<p>Latanoprost\x20is\x20a\x20prostaglandin\x20analog\x20that\x20is\x20a\x20PGF2&alpha;\x20derivative.\x20It\x20reduces\x20intraocular\x20pressure\x20by\x20increasing\x20uveoscleral\x20outflow.\x20It\x20is\x20not\x20used\x20in\x20the\x20treatment\x20of&nbsp;pulmonary\x20hypertension.</p>','currentQuestion','begca','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','Lidocaine','warn','lXKOP','tkfCr','MiBBf','nXXTJ','\x20-\x20Brain\x20And\x20Scalpel','ORQfm','qWPvF','hIorO','markReviewText','hBLwc','getElementById','dPjwg','KxYHo','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','hierarchy','navBtn_','EgFLU','ArrowRight','FRKwx','GeIsb','totalAttempted','Dqhit','tbYke','IEgfN','QOIFY','At\x20around\x2011.30\x20PM,\x20a\x2045-year-old\x20man\x20is\x20wheeled\x20into\x20the\x20casualty\x20with\x20anginal\x20pain\x20for\x20which\x20the\x20consultant\x20advises\x20nitrates.\x20On\x20administration\x20of\x20nitrates,\x20his\x20BP\x20suddenly\x20drops\x20and\x20the\x20patient\x20goes\x20into\x20sudden\x20hypotension.\x20On\x20probing\x20into\x20his\x20medical\x20history,\x20his\x20wife\x20mentions\x20that\x20he\x20has\x20been\x20taking\x20a\x20drug\x20for\x20erectile\x20dysfunction.\x20What\x20is\x20the\x20likely\x20mechanism\x20of\x20the\x20action\x20of\x20this\x20drug?','Increases\x20incidence\x20of\x20venous\x20thrombosis','correctAnswers','\x22\x20data-option-index=\x22','4|1|0|2|5|3','ttQsL','pfGSd','5BxlQqs','Sensitization\x20of\x20muscarinic\x20receptors','https://cdn1.dailyrounds.org/uploads/fbcd52b7772648e9a6a49d11b9f4fb45.JPEG','CzQaV','aEYtM','<p>The\x20patient\x27s\x20complaints\x20of\u00a0breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting\x20are\x20suggestive\x20of\x20anaphylactic\x20shock.\x20The\x20<strong>drug\u00a0of\x20choice</strong>\x20for\x20anaphylaxis\x20is\x20<strong>intramuscular\x20adrenaline</strong>\x20(<strong>0.5ml\x20in\x201:1000\x20dilution</strong>).\x20Activation\x20of\x20<strong>beta\x202</strong>\x20receptors\x20causes<strong>\x20bronchodilation</strong>.\x20Hence,\x20adrenaline\x20action\x20on\x20the\x20beta\x202\x20receptors\x20improves\x20the\x20breathing\x20difficulty\x20in\x20this\x20patient.\x20Apart\x20from\x20this,\x20beta\x202\x20receptors\x20also\x20inhibit\x20the\x20secretion\x20from\x20mast\x20cells.</p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<table\x20style=\x22height:\x2099px;\x22\x20width=\x22456\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22><strong>Receptor</strong></td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22><strong>Action</strong></td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22><strong>Use\x20in\x20anaphylaxis\x20treatment\u00a0</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Alpha\x201\x20and\x20Alpha\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Vasoconstriction</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x201</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Cardiac\x20stimulation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Increase\x20in\x20BP</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2086.28125px;\x22>Beta\x202</td>\x0a<td\x20style=\x22width:\x20157.734375px;\x22>Bronchodilation</td>\x0a<td\x20style=\x22width:\x20190.015625px;\x22>Reverse\x20bronchoconstriction\u00a0</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><br\x20/>The\x20net\x20effect\x20of\x20adrenaline\x20on\x20BP:\x20Adrenaline\x20rapidly\x20<strong>increases\x20blood\x20pressure</strong>\x20by\x20reversing\x20vasodilation\x20and\x20improving\x20cardiac\x20output.\x20This\x20is\x20critical\x20for\x20preventing\x20shock\x20and\x20ensuring\x20adequate\x20perfusion\x20to\x20vital\x20organs\x20during\x20anaphylaxis.</p>','fBpZX','WRHiG','Tpmhy','onclick','ETbLZ','notAttempted','rATRM','Prostate\x20cancer','Antagonist\x20action\x20on\x20dopamine\x20receptors','referrer','9751JgUfNw','1,\x202,\x203,\x204\x20&\x205','questionNav','Ydess','gSLdT','EQFlG','isSupported','AaItg','NEET\x20PG\x20Mini\x20Test\x20Series','</span><span>','Ynaqy','agkiN','Kwajf','markedForReview','Utrnh','markReviewBtn','UQBMR','QUALx','submitSection','Previous\x20progress\x20cleared.','HIRoC','CpMGd','hyFgR','explanationVideoPlayer','GqGMx','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','text','bvuXQ','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','reload','jBPBs','iJmDx','border-green-500','__proto__','kCJxl','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','jHTUj','UGdZm','orImr','timed_exam','stringify','wUyxr','dWTmr','vqaGe','ADlcQ','explanation_audio_hin','Fasudil','explanation_images','tXsGG','dYgHI','answered','DsZaD','Thalidomide\x20+\x20Cyclophosphamide','RPJGc','Phosphodiesterase\x202\x20inhibitors','svYqI','hkfFX','rKEJo','Esmolol','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','<p><strong>Nitroprusside</strong>\x20can\x20be\x20used\x20as\x20an\x20antidote\x20to\x20reverse\x20the\x20ergot-induced\x20vasospasm.</p>\x0a<p>Nitroprusside\x20is\x20a\x20non-selective\x20vasodilator.\x20It\x20acts\x20by\x20releasing\x20NO,\x20which\x20activates\x20the\x20guanylyl\x20cyclase\x20-\x20cyclic\x20GMP\x20–\x20protein\x20kinase\x20G\x20pathway,\x20leading\x20to\x20vasodilation.\x20This\x20mechanism\x20mimics\x20the\x20production\x20of\x20NO\x20by\x20vascular\x20endothelial\x20cells.</p>\x0a<p><strong>Therapeutic\x20uses:</strong></p>\x0a<ul>\x0a<li>It\x20is\x20primarily\x20used\x20in\x20the\x20treatment\x20of\x20<strong>hypertensive</strong>\x20<strong>emergencies</strong>.</li>\x0a<li>To\x20lower\x20blood\x20pressure\x20during\x20<strong>aortic</strong>\x20<strong>dissection</strong>.\x20It\x20is\x20important\x20to\x20administer\x20beta\x20blocker\x20with\x20nitroprusside\x20in\x20aortic\x20dissection\x20to\x20reduce\x20heart\x20rate,\x20because\x20if\x20nitroprusside\x20is\x20given\x20alone,\x20it\x20causes\x20increased\x20myocardial\x20contractility,\x20which\x20in\x20turn\x20increases\x20the\x20rate\x20of\x20increase\x20in\x20aortic\x20pressure\x20and\x20may\x20further\x20aggravate\x20the\x20dissection.</li>\x0a<li>To\x20improve\x20cardiac\x20output\x20in\x20patients\x20with\x20<strong>congestive</strong>\x20<strong>heart</strong>\x20<strong>failure</strong>,\x20especially\x20with\x20hypertension\x20and\x20pulmonary\x20edema,\x20who\x20are\x20refractory\x20to\x20other\x20treatments.</li>\x0a<li>To\x20decrease\x20myocardial\x20oxygen\x20demand\x20after\x20<strong>myocardial</strong>\x20<strong>infarction</strong>.</li>\x0a<li>To\x20induce\x20controlled\x20hypotension\x20during\x20anesthesia,\x20and\x20reduce\x20bleeding\x20during\x20<strong>surgical</strong>\x20<strong>procedures</strong>.</li>\x0a<li>To\x20reverse\x20the\x20vasospastic\x20action\x20of\x20the\x20<strong>ergot</strong>\x20<strong>alkaloids</strong>,\x20such\x20as\x20ergotamine\x20and\x20ergonovine.</li>\x0a</ul>','wChHr','Dacarbazine','1,\x203,\x204\x20&\x205','aNfDa','nHDlW','classList','YqnYe','incorrectResult','table','yQAoZ','toggle','Jrzwi','disabled','OYuOe','TMrpo','OGhHx','DrzeZ','AMIyI','oAMsS','VGDmX','oqVKS','question_video','rqGrU','LRUcX','strkK','MEmgH','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','4-5-2-3-1','console','EFAdu','totalTimeResult','QyfZy','NArvL','jLeVs','error','FTjwb','log','progressBar','Not\x20Attempted','Ondansetron','dZxDx','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','PBEaS','<p>This\x20patient\x27s\x20history\x20and\x20clinical\x20findings\x20are\x20suggestive\x20of\x20multiple\x20myeloma.<strong><span\x20data-preserver-spaces=\x22true\x22>\x20Lenalidomide\x20+Bortezomib+Dexamethasone\x20</span></strong>is\x20the\x20treatment\x20of\x20choice\x20in<strong><span\x20data-preserver-spaces=\x22true\x22>\u00a0multiple\x20myeloma.</span></strong></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>This\x20patient\x27s\x20anemia,\x20hypercalcemia,\x20normal\x20alkaline\x20phosphatase,\x20elevated\x20ESR\x20are\x20consistent\x20with\x20the\x20diagnosis\x20of\x20multiple\x20myeloma.\x20The\x20<strong>skull</strong>\x20demonstrates\x20the\x20typical\u00a0<strong>“punched\x20out”\x20lesions</strong>\u00a0characteristic\x20of\x20multiple\x20myeloma.\u00a0</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>Multiple\x20myeloma\x20is\x20a\x20malignant\x20<strong>plasma\x20cell\x20dyscrasia</strong>\x20with\x20the\x20proliferation\x20of\x20plasma\x20cells\x20derived\x20from\x20a\x20single\x20clone.\x20Bone\x20pain\x20is\x20the\x20most\x20common\x20presenting\x20symptom\x20in\x20multiple\x20myeloma.\u00a0</span>The\x20next\x20most\x20common\x20clinical\x20problem\x20in\x20patients\x20with\x20myeloma\x20is\x20susceptibility\x20to\x20bacterial\x20infections.\x20The\x20most\x20common\x20infections\x20are\x20pneumonia\x20and\x20pyelonephritis,\x20and\x20the\x20most\x20frequent\x20pathogens\x20are\x20<em>Streptococcus\x20pneumoniae</em>,\x20<em>Staphylococcus\x20aureus</em>,\x20and\x20<em>Klebsiella\x20pneumoniae</em>\x20in\x20the\x20lungs\x20and\x20<em>Escherichia\x20coli</em>\x20and\x20other\x20gram-negative\x20organisms\x20in\x20the\x20urinary\x20tract.</p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22><strong>Chemotherapy</strong>\x20followed\x20by\x20<strong>a</strong><strong>utologous\x20stem\x20cell\x20transplantation</strong>\u00a0prolongs\x20overall\x20survival\x20in\x20multiple\x20myeloma\x20patients.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>The\x20combination\x20of\x20lenalidomide,\x20bortezomib,\x20and\x20dexamethasone\x20achieves\x20close\x20to\x20a\x20100%\x20response\x20rate\x20making\x20it\x20one\x20of\x20the\x20preferred\x20induction\x20regimens\x20in\x20transplant-eligible\x20patients.</span></p>\x0a<p><span\x20data-preserver-spaces=\x22true\x22>NOTE:\x20The\x20U.S.\x20FDA\x20has\x20approved\x20ABECMA,\x20the\x20first\x20cell-based\x20gene\x20therapy\x20to\x20treat\x20adult\x20patients\x20with\x20multiple\x20myeloma\x20who\x20have\x20not\x20responded\x20to,\x20or\x20whose\x20disease\x20has\x20returned\x20after,\x20at\x20least\x20four\x20prior\x20lines\x20(different\x20types)\x20of\x20therapy.</span></p>','eyIrs','<div\x20class=\x22mt-4\x22><img\x20src=\x22','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','plRuu','ZYdiA','application/vnd.apple.mpegurl','pathname','study','omUPV','cTyqy','ltsrX','DQCHc','ZFtDd','explanation_video','hhLfP','juuJZ','nav-btn-marked-review','A\x2020-year-old\x20male\x20patient\x20presents\x20to\x20the\x20emergency\x20department\x20with\x20complaints\x20of\x20breathing\x20difficulty,\x20facial\x20swelling,\x20and\x20palpitations\x20following\x20a\x20bee\x20sting.\x20He\x20was\x20immediately\x20given\x20an\x20intramuscular\x20injection\x20of\x20a\x20drug\x20in\x201:1000\x20dilution.\x20The\x20drug\x20acts\x20on\x20which\x20of\x20the\x20following\x20receptor\x20to\x20improve\x20the\x20patient\x27s\x20breathing\x20difficulty?','A\x2027-year-old\x20male\x20patient\x20presents\x20with\x20bands\x20of\x20pruritic,\x20flagellate,\x20and\x20erythematous\x20lesions\x20over\x20the\x20trunk\x20and\x20extremities.\x20He\x20is\x20a\x20known\x20case\x20of\x20Hodgkin’s\x20lymphoma\x20and\x20is\x20on\x20treatment\x20with\x20an\x20ABVD\x20regimen\x20for\x20the\x20past\x204\x20months.\x20What\x20is\x20the\x20drug\x20responsible\x20for\x20the\x20presenting\x20features?','includes','ENsCm','wPhvY','PPLPJ','target','rtAjL','abrCE','PzrWH','explanation_audio_eng','SDqZw','KUmRl','5169102Oelhym','fill','A\x2023-year-old\x20pregnant\x20woman\x20presented\x20with\x20features\x20suggestive\x20of\x20thyrotoxicosis.\x20Which\x20of\x20the\x20following\x20is\x20not\x20a\x20treatment\x20option\x20for\x20her\x20condition?','correct_choice_id','HgQpe','test','accuracy','FiLwr','\x20>\x20','bhgCm','XgrWs','BvPDN','A\x2035-year-old\x20woman\x20came\x20to\x20the\x20emergency\x20department\x20with\x20severe\x20pain\x20in\x20both\x20legs,\x20after\x20she\x20underwent\x20an\x20induced\x20abortion\x20using\x20ergotamine.\x20On\x20examination,\x20her\x20legs\x20were\x20cold\x20and\x20pale,\x20and\x20peripheral\x20arterial\x20pulses\x20were\x20not\x20felt.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20as\x20an\x20antidote\x20in\x20treating\x20the\x20condition?','vFlEa','testModeReviewLegend','cRKZY','jEemo','rAght','TsQgf','LdWAl','strokeDasharray','oCweL','OmIXR','yJGuK','SQihu','Aflibercept','nuBzH','WWNxT','Timolol','KEMnk','<p>The\x20pulsatile\x20dose\x20of\x20GnRH\x20agonist\x20is\x20used\x20in\x20the\x20treatment\x20of\x20male\x20infertility.</p>\x0a<p><strong>Pulsatile</strong>\x20<strong>administration</strong>\x20of\x20GnRH\x20agonist\x20<strong>increases\x20FSH\x20and\x20LH</strong>\x20secretion\x20and\x20is\x20used\x20to<strong>\x20treat\x20male\x20and\x20female\x20infertility</strong>.</p>\x0a<p>A\x20non-pulsatile\x20or\x20a\x20continuous\x20dose\x20of\x20GnRH\x20agonist\x20results\x20in\x20suppression\x20and\x20decreased\x20concentrations\x20of\x20gonadotropins\x20(LH\x20and\x20FSH).\x20Hence,\x20it\x20cannot\x20be\x20used\x20in\x20the\x20treatment\x20of\x20male\x20infertility.\u00a0</p>\x0a<p>Non-pulsatile\x20(Continuous)\x20administration\x20of\x20GnRH\x20analogs\x20used\x20in:\u00a0</p>\x0a<ul>\x0a<li>Endometriosis</li>\x0a<li>Uterine\x20fibroids</li>\x0a<li>Central\x20precocious\x20puberty</li>\x0a<li>Ca\x20prostate</li>\x0a<li>Ca\x20ovary\x20and\x20breast</li>\x0a<li>Controlled\x20ovary\x20stimulation</li>\x0a</ul>','MYDwy','querySelectorAll','Sodium\x20valproate','forEach','TfECs','A\x20patient\x20was\x20given\x20metoclopramide\x20for\x20severe\x20vomiting.\x20\x20After\x20which\x20he\x20developed\x20symptoms\x20like\x20acute\x20dystonia,\x20bradykinesia,\x20and\x20tremors.\x20The\x20observed\x20adverse\x20effects\x20are\x20due\x20to?','customQuizData','zkxQU','qphzd','ECvYQ','OLSWL','aBNhL','XplJZ','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','nav-btn-current','Bisacodyl','Progress\x20loaded.','kqzSZ','CAXJZ','fAVys','tLrBv','Deytb','open','aBvvx','ggwez','yNwLP','svOdz','A\x2058-year-old\x20patient\x20came\x20to\x20the\x20hospital\x20with\x20complaints\x20of\x20sudden\x20onset\x20of\x20severe\x20pain\x20in\x20the\x20right\x20side\x20of\x20lips,\x20gums,\x20and\x20cheek.\x20It\x20occurs\x20during\x20both\x20day\x20and\x20night\x20and\x20lasts\x20for\x202-3\x20min\x20and\x20has\x20been\x20present\x20for\x203\x20weeks.\x20What\x20is\x20the\x20primary\x20agent\x20in\x20the\x20treatment\x20of\x20this\x20condition?','WUHmC','QWrEG','<div\x20class=\x22page\x22\x20title=\x22Page\x20818\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>This\x20post-menopausal\x20patient\x20with\x20a\x20family\x20history\x20of\x20breast\x20cancer,\x20with\x20osteoporosis&nbsp;(low\x20back\x20pain,\x20a\x20T-score\x20of\x20-2.6),\x20has\x20been\x20recommended\x20to\x20take\x20raloxifene.\x20Raloxifene\x20causes\x20a\x20<strong>3-fold\x20increase\x20</strong>in\x20<strong>deep\x20vein\x20thrombosis</strong>\x20and\x20pulmonary\x20embolism.</p>\x0a<p>It\x20is\x20a\x20selective\x20estrogen\x20receptor\x20modulator&nbsp;<strong>(SERM)</strong>\x20with\x20the\x20following\x20actions-</p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a<p>Agonist\x20actions:</p>\x0a<ul>\x0a<li>Bone:\x20Increases\x20bone\x20mineral\x20density\x20and\x20<strong>reduces\x20</strong>the\x20risk\x20of<strong>\x20vertebral\x20fractures</strong></li>\x0a<li>Lipids:\x20Reduces\x20total\x20cholesterol\x20and\x20low-density\x20lipoprotein.\x20However,\x20it\x20does\x20not\x20increase\x20HDL\x20cholesterol.</li>\x0a<li>Increases\x20the\x20<strong>risk</strong>\x20of\x20<strong>deep\x20vein\x20thrombosis</strong>\x20and<strong>\x20pulmonary\x20embolism.&nbsp;</strong></li>\x0a</ul>\x0a<p>Antagonist\x20action:</p>\x0a<ul>\x0a<li>Breast:\x20<strong>Incidence\x20of\x20breast\x20carcinoma\x20is\x20reduced</strong>\x20(option\x20D).&nbsp;Raloxifene\x20has\x20an\x20antiproliferative\x20effect\x20on\x20ER-positive\x20breast\x20tumors\x20and\x20significantly\x20reduces\x20the\x20risk\x20of\x20ER-positive\x20but\x20not\x20ER-negative\x20breast\x20cancer.</li>\x0a<li>Uterus:\x20does\x20<strong>not</strong>\x20stimulate&nbsp;<strong>endometrial\x20proliferation</strong>&nbsp;(option\x20B)</li>\x0a</ul>\x0a<p>Note:\x20Raloxifene\x20does\x20not\x20help\x20with\x20vasomotor\x20symptoms,\x20and\x20some\x20people\x20might\x20experience\x20hot\x20flashes&nbsp;(option\x20A).</p>\x0a<table\x20style=\x22width:\x20420.297px;\x20height:\x20164px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2080px;\x22>SERM</td>\x0a<td\x20style=\x22width:\x20105px;\x22>Effect\x20on\x20breast&nbsp;</td>\x0a<td\x20style=\x22width:\x20104px;\x22>Effect\x20on\x20endometrium</td>\x0a<td\x20style=\x22width:\x2094.2969px;\x22>Effect\x20on\x20bone</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2080px;\x22>Tamoxifen</td>\x0a<td\x20style=\x22width:\x20105px;\x22>Inhibits\x20proliferation</td>\x0a<td\x20style=\x22width:\x20104px;\x22><strong>Stimulates\x20proliferation</strong></td>\x0a<td\x20style=\x22width:\x2094.2969px;\x22>Antiresorptive</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2080px;\x22>Raloxifene</td>\x0a<td\x20style=\x22width:\x20105px;\x22>Inhibits\x20proliferation</td>\x0a<td\x20style=\x22width:\x20104px;\x22><strong>Inhibits\x20proliferation</strong></td>\x0a<td\x20style=\x22width:\x2094.2969px;\x22>Antiresorptive</td>\x0a</tr>\x0a</tbody>\x0a</table>','rgptq','hidden','<p>The\x20clinical\x20symptoms\x20are\x20suggestive\x20of\x20trigeminal\x20neuralgia<strong>.\x20Carbamazepine</strong>\x20is\x20the\x20<strong>primary\x20agent</strong>\x20for\x20the\x20treatment\x20of\x20<strong>trigeminal\x20neuralgia</strong>.\x20If\x20carbamazepine\x20is\x20not\x20effective\x20then\x20second-line<strong>\u00a0</strong>agents\x20like\x20lamotrigine\x20and\x20phenytoin\x20are\x20used.\u00a0</p>\x0a<p><strong>Trigeminal\x20neuralgia</strong>\x20is\x20more\x20common\x20in\x20women\x20over\x20<strong>50\x20years</strong>\x20of\x20age.\x20It\x20is\x20characterized\x20by\x20unilateral\x20lancinating\x20<strong>facial\x20pain</strong>,\x20most\x20commonly\x20involving\x20the\x20second\x20and/or\x20third\x20divisions\x20of\x20the\x20trigeminal\x20nerve\x20territory.\x20Bilateral\x20or\x20early\x20onset\x20is\x20associated\x20with\x20multiple\x20sclerosis.\x20Unilateral\x20trigeminal\x20nerve\x20compresion\x20can\x20be\x20due\x20to\x20superior\x20cerebellar\x20artey.</p>\x0a<p>The\x20pain\x20is\x20<strong>repetitive,\x20severe</strong>,\x20and\x20very\x20brief.\x20This\x20occurs\x20spontaneously\x20or\x20is\x20triggered\x20by\x20<strong>touch,\x20cold\x20wind</strong>,\x20or\x20<strong>eating</strong>.\x20Physical\x20signs\x20are\x20usually\x20absent,\x20although\x20the\x20spasms\x20may\x20make\x20the\x20patient\x20wince\x20and\x20sit\x20silently\x20(tic\x20douloureux).\x20There\x20are\x20no\x20objective\x20signs\x20of\x20sensory\x20loss.\u00a0</p>','BhNhR','selectedAnswer','A\x20patient\x20diagnosed\x20with\x20renal\x20cell\x20carcinoma\x20was\x20started\x20on\x20a\x20tyrosine\x20kinase\x20inhibitor\x20that\x20acts\x20by\x20inhibiting\x20VEGF.\x20He\x20is\x20now\x20being\x20evaluated\x20for\x20increasing\x20protein\x20excretion\x20in\x20his\x20urine.\x20Which\x20of\x20the\x20following\x20drugs\x20was\x20prescribed\x20to\x20the\x20patient?','questions','Carbamazepine','QmFGx','oPVja','solutionAudio','A\x20patient\x20was\x20started\x20on\x20a\x20drug\x20for\x20the\x20treatment\x20of\x20glaucoma.\x20He\x20presents\x20with\x20complaints\x20of\x20extensive\x20loss\x20of\x20orbital\x20fat\x20giving\x20the\x20appearance\x20of\x20a\x20sunken\x20eye.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20cause\x20this\x20side\x20effect?','hTcZb','solutionText','statsBar','rhYRy','incorrectCount','Subtotal\x20thyroidectomy','oeYDo','GXINw','<p><strong>Erectile\x20dysfunction</strong>&nbsp;is\x20treated\x20by\x20<strong>phosphodiesterase\x205\x20</strong>(PDE-5)<strong>\x20inhibitors</strong>\x20like\x20<strong>sildenafil,\x20vardenafil,\x20</strong>and\x20<strong>tadalafil.\x20</strong>PDE-5\x20inhibitors\x20and\x20nitrates\x20should\x20<strong>not</strong>\x20be\x20prescribed\x20together\x20due\x20to<strong>&nbsp;an\x20increased\x20risk\x20</strong>of<strong>\x20hypotension</strong>.</p>\x0a<p>The\x20corpus\x20cavernosum\x20produces\x20nitric\x20oxide\x20during\x20arousal\x20that\x20stimulates\x20the\x20formation\x20of\x20cGMP.\x20cGMP\x20causes\x20relaxation\x20of\x20the\x20smooth\x20muscle\x20of\x20the\x20corpus\x20cavernosum\x20and\x20penile\x20arteries,\x20engorgement\x20of\x20the\x20corpus\x20cavernosum,\x20and\x20erection.&nbsp;<strong>PDE-5\x20inhibitors\x20</strong>enhance\x20the\x20<strong>accumulation\x20</strong>of\x20<strong>cGMP\x20</strong>and\x20are,\x20therefore,\x20used\x20in\x20the\x20management\x20of\x20erectile\x20dysfunction.</p>\x0a<p><strong>Drug\x20interactions\x20</strong>of\x20PDE-5\x20and\x20nitrates<strong>-&nbsp;</strong>PDE-5\x20inhibitors\x20enhance\x20the\x20accumulation\x20of\x20cGMP\x20by\x20preventing\x20its\x20degradation\x20and\x20therefore\x20cause\x20vasodilation.\x20Since\x20nitrates\x20also\x20act\x20by\x20increasing\x20cyclic\x20GMP\x20mechanism,\x20they\x20can\x20therefore\x20potentiate\x20the\x20effects\x20of\x20PDE-5\x20inhibitors.\x20Hence,\x20men\x20treated\x20with\x20PDE-5\x20inhibitors\x20and\x20nitrates\x20are\x20at\x20risk\x20for<strong>\x20severe\x20hypotension\x20</strong>and<strong>\x20syncope.</strong></p>\x0a<p><strong>Adverse\x20effects\x20of\x20PDE-5\x20inhibitors-</strong></p>\x0a<ul>\x0a<li>The\x20most\x20common\x20side\x20effects\x20reported\x20include\x20headache,\x20flushing,\x20nasal\x20congestion,\x20nasopharyngitis,\x20and\x20dyspepsia.\x20Rare\x20but\x20serious\x20reports\x20of\x20prolonged\x20erections\x20lasting\x20more\x20than\x204\x20hours\x20and\x20priapism\x20(painful\x20erections\x20lasting\x20more\x20than\x204\x20hours)\x20have\x20been\x20reported\x20with\x20PDE<sub>5</sub>&nbsp;inhibitors.&nbsp;</li>\x0a<li><strong>Sildenafil\x20</strong>and<strong>\x20vardenafil</strong>&nbsp;also\x20cause\x20retinal\x20PDE-6\x20inhibition\x20and\x20can\x20result\x20in\x20blurring\x20of\x20vision\x20and\x20<strong>blue-green\x20tinting\x20of\x20the\x20vision</strong>.&nbsp;</li>\x0a</ul>','contains','green','QkUwT','Vigabatrin','yAMez','nav-btn-correct','PHSZg','No\x20question\x20text\x20available','fromCharCode','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','qFvjS','button','yqUxu','gray','filter','DSCtD','ZRiYF','gFVwC','AQIUh','KAbPC','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','VrkUr','BIKaF','Rrxdj','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','not-attempted','XFalU','IRjPS','boMmm','RZLka','DgYBy','strokeDashoffset','PreEN','LjRXI','addEventListener','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','NBeLj','toString','bookmarked','lhurc','Beta\x202','join','gdEUA','No\x20questions\x20available\x20for\x20this\x20quiz.','nmHqu','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','eboPa','quizSidebar','OsUSx','remove','TItqC','Beta\x201','lFnQk','LuXit','xsEPP','apply','No\x20solution\x20provided','innerHTML','hDeur','srsmE','bgUnx','return\x20(function()\x20','closest','mukAX','EMGTR','oYBbH','qoAIK','zLuBW','mjncf','currentQuestionIndex','Bleomycin','questionReviewSection','reviewQuestionsContainer','bZmYC','TxPFS','VPiCF','style','Scopalamine','EWOyz','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','rAAZI','DFPEu','wnsiV','pObrI','soqxH','YdTJU','Antagonistic\x20action\x20on\x20serotonin\x205HT3\x20receptor','quizPerformanceData','MHpSu','UvgJg','gDFQq','canPlayType','Vmtdb','CQVXU','jCElf','mYgcJ','kHHPQ','A\x20patient\x20with\x20pulmonary\x20hypertension\x20comes\x20for\x20a\x20vasoreactivity\x20test.\x20What\x20drugs\x20can\x20be\x20used\x20if\x20the\x20test\x20is\x20negative?','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','optionsContainer','AsiBw','qFyQo','Endometriosis','exVBv','Option\x20','LYHtx','quizHierarchy','zBuPg','GIUli','solution','cMecS','vzrzI','SijYJ','qpvAi','SaqQq','EaAeJ','https://dhmbxeygs57ff.cloudfront.net/uploads/c5a000b0a75e4c4387bf23f0c11b5725x720x854.PNG','Bookmarked','Lubiprostone','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','Male\x20infertility','prototype','true','dataset','Ksplu','isArray','<p>In\x20the\x20above\x20scenario,\x20the\x20patient\x20has\x20developed&nbsp;<strong>extrapyramidal</strong>\x20adverse\x20effects\x20like\x20<strong>acute\x20dystonia,</strong>\x20<strong>bradykinesia</strong>,\x20and<strong>\x20tremors.\x20</strong>This\x20is\x20likely\x20due\x20to<strong>&nbsp;</strong>the&nbsp;<strong>antagonist</strong>\x20action\x20on\x20<strong>dopamine\x20receptors</strong>\x20by\x20<strong>metoclopramide.</strong></p>\x0a<p>Metoclopramide\x20is\x20a\x20<strong>prokinetic</strong>\x20and\x20<strong>antiemetic.</strong>\x20It\x20has\x20the\x20following\x20<strong>pharmacological\x20actions:</strong></p>\x0a<ul>\x0a<li><strong>Dopamine</strong>\x20receptor\x20<strong>antagonist</strong>&nbsp;</li>\x0a<li>Serotonin\x20(<strong>5HT4</strong>)\x20receptor\x20<strong>agonist</strong>&nbsp;</li>\x0a<li>Serotonin\x20(<strong>5HT3</strong>)\x20<strong>antagonist</strong></li>\x0a<li><strong>Sensitization</strong>\x20of\x20<strong>muscarinic\x20receptors</strong>\x20on\x20<strong>smooth\x20muscle.</strong>\x20This\x20results\x20in\x20<strong>increased</strong>\x20lower\x20<strong>esophageal\x20sphincter\x20tone</strong>\x20and\x20stimulates\x20gastric\x20antral\x20contractions.</li>\x0a</ul>\x0a<p>Metoclopramide\x20acts\x20on\x20both\x20the\x20gastrointestinal\x20system\x20and\x20central\x20nervous\x20system.\x20It\x20is\x20used\x20as\x20an\x20upper\x20antiemetic\x20for\x20many\x20types\x20of\x20vomiting,\x20especially\x20migraine,\x20drug-induced,\x20and<strong>\x20chemotherapy-induced</strong>.\x20It\x20is\x20also\x20used\x20as\x20a\x20prokinetic\x20in\x20<strong>gastroparesis</strong>\x20to\x20increase\x20gastric\x20emptying.</p>\x0a<p>Adverse\x20effects\x20of\x20metoclopramide\x20are\x20mainly\x20extrapyramidal\x20effects,\x20and\x20these\x20include\x20<strong>acute\x20dystonia,\x20Parkinson</strong><strong>-like</strong>\x20symptoms\x20(tremors,\x20bradykinesia,\x20rigidity),\x20tardive\x20dyskinesia,<strong>\x20galactorrhea\x20</strong>due\x20to\x20hyperprolactinemia,\x20and\x20methemoglobinemia\x20in\x20neonates.</p>\x0a<p>Extrapyramidal\x20symptoms\x20can\x20be\x20<strong>treated</strong>\x20by\x20<strong>discontinuation</strong>\x20of\x20metoclopramide\x20and\x20administration\x20of\x20anticholinergics\x20or\x20antihistaminics.</p>','MEOZO','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','loadSource','yeitD','<p><strong>Lactulose</strong>\x20is\x20safe\x20to\x20use\x20in\x20pregnant\x20women\x20with\x20constipation.</p>\x0a<p><strong>Constipation\x20in\x20pregnancy:</strong></p>\x0a<p>Constipation\x20is\x20a\x20common\x20occurrence\x20in\x20pregnancy\x20because\x20of\x20dietary\x20alterations,\x20anatomic\x20impingement\x20of\x20a\x20large\x20uterus\x20on\x20the\x20rectosigmoid,\x20fluid\x20shifts,\x20decreased\x20exercise\x20levels,\x20and\x20reduced\x20mobility.\x20Pregnancy\x20and\x20pregnancy-related\x20constipation\x20increases\x20the\x20risk\x20for\x20developing\x20haemorrhoids.</p>\x0a<p>Treatment\x20options\x20include</p>\x0a<ul>\x0a<li>Dietary\x20changes\x20-\x20increased\x20water\x20intake,\x20increased\x20fibre\x20in\x20diet</li>\x0a<li>Gentle\x20exercises</li>\x0a<li>Laxatives\x20-\x20<strong>Lactulose,\x20</strong>an\x20osmotic\x20purgative,<strong>&nbsp;</strong>and\x20<strong>Ispaghula,</strong>\x20a\x20bulk\x20forming\x20agent,\x20are\x20safe\x20to\x20use\x20in\x20pregnancy.&nbsp;</li>\x0a</ul>\x0a<p>Senna,\x20bisacodyl,\x20docusates\x20and\x20saline\x20laxatives&rsquo;\x20<strong>safety</strong>\x20is\x20<strong>unknown</strong>\x20and\x20hence\x20it\x20is\x20better\x20to\x20<strong>avoid</strong>\x20them.</p>','egKIg','totalQuestions','YiObO','ngiHU','performanceModal','TVBzJ','resume','zpxiG','Diphenhydramine','UkNFa','padStart','rygwt','mFshP','scoreCircle','keydown','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','cYUFl','7586iTnrdB','choices','DaSZx','aPPry','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','DgFmW','WuQyK','LTEoN','kKMxj','IkZYY','KgNMO','FnrWZ','YMkuP','niopM','name','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','Ivabradine','GMHPe','Alpha\x202','click','not_attempted','endsWith','VRmfO','floor','getAttribute','bookmarkedQuestions','review-question\x20','bQWcN','KtIwH','userHistory','questionIndex','ZjVGo','wSeAB','UOuav','Docusates','UkOOM','hIlAG','dxWum','removeItem','119nobeAf','timerContainer','stats','cGRDY','ArrowLeft','SaLYi','A\x20pregnant\x20woman\x20presents\x20to\x20your\x20OPD\x20with\x20severe\x20constipation.\x20After\x20ruling\x20out\x20pathological\x20causes,\x20which\x20of\x20the\x20following\x20is\x20the\x20safest\x20to\x20prescribe?','solutionContainer','length','.option-button','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','ZJwJZ','Incorrect','QaPyo','SVPxJ','now','gGMcV','createElement','incorrect','cMjpU','eIJFt','ffrBx','Pembrolizumab','VgYIt','mOPtA','findIndex','Meclizine','Hydrocodone','LRHIJ','ZFnFU','<p><strong>Sunitinib</strong>\x20is\x20a\x20small\x20molecule,\x20<strong>multi-targeted\x20kinase\x20antagonist/inhibitor</strong>\x20and\x20has\x20been\x20shown\x20to\x20have\x20<strong>anti-tumor\x20activity\x20</strong>in\x20<strong>renal\x20cell\x20carcinoma\x20(RCC)</strong>,\x20<strong>gastrointestinal\x20stromal\x20tumor</strong>\x20(GIST)\x20and\x20<strong>pancreatic\x20neuroendocrine\x20tumors</strong>\x20(pNETs).\x20<strong>Proteinuria</strong>\x20is\x20a\x20common\x20adverse\x20effect\x20of\x20the\x20drug.\u00a0</p>\x0a<p><strong>Pharmacology</strong>\x20of\x20sunitinib:</p>\x0a<ul>\x0a<li>Molecular\x20targets\x20of\x20sunitinib\x20are\x20<strong>c-Kit,\x20VEGFR-2,\x20PDGFR-β</strong>\x20and\x20<strong>Flt-3.</strong></li>\x0a<li>Sunitinib\x20targets\x20mutations\x20in\x20the\x20RET\x20gene.</li>\x0a<li>The\x20<strong>mechanisms</strong>\x20of\x20<strong>sunitinib’s\x20action</strong>\x20are:Inhibition\x20of\x20activated\x20c-Kit\x20and\x20PDGFR\x20in\x20GIST</li>\x0a<li>Inhibition\x20of\x20VEGFR\x20in\x20advanced\x20RCC</li>\x0a</ul>\x0a<p><strong>Adverse\x20effects:</strong></p>\x0a<ul>\x0a<li><strong>Its</strong>\x20specific\x20adverse\x20effects\x20include\x20<strong>neutropenia,\x20diarrhea</strong>\x20and\x20<strong>fatigue.</strong></li>\x0a<li>Generally,\x20the\x20other\x20common\x20side\x20effects\x20of\x20agents\x20having\x20anti-VEGFR\x20activity\x20are\x20<strong>hypertension</strong>\x20and\x20<strong>proteinuria.</strong></li>\x0a<li>Rarely,\x20they\x20cause\x20<strong>bleeding</strong>\x20and\x20<strong>clotting\x20disorders,</strong>\x20and\x20<strong>perforation</strong>\x20of\x20<strong>scarred\x20gastrointestinal\x20lesions.</strong></li>\x0a<li>Hand-foot\x20syndrome\x20has\x20also\x20been\x20noted\x20in\x20the\x20use\x20of\x20these\x20agents,\x20with\x20erythema\x20and\x20desquamation\x20of\x20distal\x20extremities.</li>\x0a</ul>\x0a<p><strong>Administration:</strong>\x20In\x20advanced\x20RCC\x20and\x20in\x20adjuvant\x20therapy,\x20sunitinib\x20is\x20given\x20<strong>orally,</strong>\x20at\x20a\x20dose\x20of\x20<strong>50mg\x20per\x20day,</strong>\x20once\x20daily,\x20with\x20or\x20without\x20food,\x20for\x20<strong>4\x20weeks</strong>\x20out\x20of\x206\x20(nine\x206-week\x20cycles\x20in\x20adjuvant\x20therapy).</p>\x0a<p>Uses:</p>\x0a<ul>\x0a<li>In\x20<strong>metastatic\x20GIST,</strong>\x20the\x20main\x20chemotherapeutic\x20agent\x20used\x20is\x20imatinib,\x20which\x20is\x20a\x20selective\x20inhibitor\x20of\x20the\x20c-kit\x20tyrosine\x20kinase.\x20Patients\x20whose\x20tumors\x20have\x20become\x20refractory\x20to\x20imatinib\x20benefit\x20from\x20agents\x20like\x20sunitinib,\x20which\x20also\x20inhibits\x20c-kit\x20tyrosine\x20kinase.</li>\x0a<li>It\x20is\x20now\x20undergoing\x20studies\x20for\x20efficacy\x20in\x20hepatocellular\x20carcinoma.</li>\x0a</ul>\x0a<p>Update:</p>\x0a<ul>\x0a<li>The\x20drug\x20was\x20previously\x20approved\x20for\x20use\x20by\x20various\x20regulatory\x20bodies\x20in\x202006,\x20for\x20conditions\x20like\x20GIST\x20and\x20advanced\x20RCC.</li>\x0a<li>In\x202017,\x20<strong>sunitinib\x20maleate</strong>\x20was\x20approved\x20by\x20the\x20FDA\x20for\x20use\x20as\x20<strong>adjuvant\x20therapy</strong>\x20for\x20patients\x20at\x20risk\x20for\x20<strong>recurrence</strong>\x20of\x20<strong>RCC</strong>\x20after\x20a\x20kidney\x20has\x20been\x20removed\x20<strong>(nephrectomy).</strong></li>\x0a<li>This\x20was\x20based\x20on\x20a\x20multi-center,\x20international,\x20double-blinded,\x20placebo-controlled\x20trial\x20among\x20615\x20patients\x20with\x20high\x20risk\x20of\x20recurrent\x20RCC\x20following\x20nephrectomy.</li>\x0a</ul>\x0a<p>Other\x20options:\u00a0</p>\x0a<p>Option\x20A:\x20<strong>Ramucirumab</strong>\x20is\x20a\x20human\x20IgG1\x20monoclonal\x20antibody\x20that\x20targets\x20<strong>VEGFR2,</strong>\x20preventing\x20<strong>VEGFR</strong>\x20ligand\x20binding\x20and\x20thereby\x20reducing\x20ligand-induced\x20activity\x20in\x20endothelial\x20cells.\x20It\x20is\x20used\x20in\x20combination\x20with\x20docetaxel\x20to\x20treat\x20patients\x20with\x20metastatic\x20non-small\x20cell\x20lung\x20cancer\x20(NSCLC).\x20Adverse\x20effects\x20include\x20<strong>hypertension</strong>\x20and\x20<strong>diarrhea.</strong></p>\x0a<p>Option\x20C:\x20<strong>Aflibercept</strong>\x20is\x20a\x20recombinant\x20fusion\x20protein\x20that\x20functions\x20as\x20a\x20VEGF\x20trap\x20by\x20sequestering\x20VEGF\x20using\x20the\x20VEGFR1-binding\x20domain.\x20It\x20is\x20used\x20in\x20treating\x20metastatic\x20colorectal\x20cancer</p>\x0a<p>Option\x20D:\x20<strong>Pembrolizumab</strong>\x20is\x20a\x20humanized\x20monoclonal\x20IgG4κ\x20isotype\x20antibody\x20that\x20prevents\x20the\x20interaction\x20between\x20programmed\x20cell\x20death\x20protein\x201\x20(PD-1)\x20and\x20its\x20ligands.\x20It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20non-small\x20cell\x20lung\x20cancer,\x20either\x20before\x20or\x20after\x20chemotherapy\x20with\x20platinum.\x20It\x20is\x20also\x20used\x20in\x20the\x20treatment\x20of\x20melanoma,\x20urothelial\x20cancer,\x20Merkel\x20cell\x20carcinoma\x20and\x20Hodgkin\x20lymphoma.\x20Serious\x20adverse\x20events\x20include\x20<strong>pneumonitis,\x20colitis</strong>\x20and\x20<strong>hepatitis.</strong></p>','Bgmvx','dgjqo','reduce','correctCount','IGtXx','studyModeLegend','toLowerCase','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','chHaF','quizFile','totalTime','push','A\x2068-year-old\x20male\x20patient\x20came\x20to\x20the\x20physician\x20with\x20complaints\x20of\x20chronic\x20back\x20pain\x20and\x20easy\x20fatigability.\x20\x20An\x20X-ray\x20of\x20his\x20skull\x20is\x20shown\x20below.\x20Laboratory\x20investigations\x20show\x20decreased\x20hemoglobin,\x20hypercalcemia,\x20normal\x20alkaline\x20phosphatase,\x20elevated\x20ESR.\x20He\x20should\x20be\x20started\x20on\x20which\x20of\x20the\x20following\x20combination\x20therapy?','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','DQLVN','eXERp','TSeFb','JSXhJ','<p>The\x20above\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20<strong>flagellate\x20dermatitis.&nbsp;</strong>It\x20is\x20a\x20specific\x20adverse\x20effect\x20of\x20<strong>bleomycin.</strong></p>\x0a<p><strong>Bleomycin</strong>&nbsp;is\x20an\x20anticancer\x20antibiotic.\x20It\x20acts\x20by\x20generating\x20free\x20radicals\x20by\x20binding\x20with\x20a\x20reducing\x20agent\x20(iron)\x20in\x20the\x20presence\x20of\x20oxygen.\x20This\x20metal-drug\x20complex\x20cleaves\x20the\x20DNA\x20of\x20the\x20tumor\x20cell.</p>\x0a<p>It\x20is\x20used\x20as\x20a\x20component\x20in\x20the\x20treatment\x20regimens\x20of&nbsp;<strong>Hodgkin\x27s\x20lymphoma</strong>\x20and<strong>\x20testicular\x20cancer</strong>.</p>\x0a<p>Bleomycin\x20has\x20a&nbsp;<strong>bone\x20marrow&ndash;sparing</strong>&nbsp;effect.\x20The\x20major\x20adverse\x20events\x20include&nbsp;<strong>flagellate\x20dermatitis</strong>\x20and\x20<strong>pulmonary\x20toxicity</strong>,\x20which\x20may\x20progress\x20to\x20pulmonary\x20fibrosis<strong>.</strong></p>\x0a<p>Flagellate\x20dermatitis\x20starts\x20as\x20bands\x20of<strong>\x20pruritic,</strong>\x20flagellate,\x20and\x20erythematous\x20lesions\x20over\x20the\x20trunk\x20and\x20extremities.\x20These\x20rashes\x20heal\x20with\x20<strong>persistent\x20flagellate\x20hyperpigmentation.&nbsp;</strong>No\x20treatment\x20is\x20necessary\x20since\x20the\x20lesions\x20usually\x20disappear\x20on\x20the\x20stoppage\x20of\x20the\x20drug.\x20These\x20lesions\x20respond\x20to\x20topical\x20corticosteroids.</p>\x0a<p>The\x20image\x20given\x20below\x20shows\x20flagellate\x20dermatitis.</p>','qdibg'];_0x2504=function(){return _0x4c1de4;};return _0x2504();}function jumpToQuestion(_0x51c7b8){const _0x108bf5=_0x291fca,_0x309568={'soEZO':function(_0x31c944){return _0x31c944();},'zQZqt':function(_0x595722,_0x254c83){return _0x595722===_0x254c83;},'VRmfO':_0x108bf5(0x2c3),'ytpkx':_0x108bf5(0x343),'dfePK':_0x108bf5(0x225),'hEfDj':function(_0x5ab7b9,_0x3b4cd4){return _0x5ab7b9<_0x3b4cd4;},'bhgCm':function(_0x3778cf,_0x42aa88){return _0x3778cf!==_0x42aa88;},'viWJi':_0x108bf5(0x1c2),'AQIUh':'CMTuZ','ADlcQ':'UjdTK','nHDlW':function(_0x3dc20f,_0x3b2d9a){return _0x3dc20f-_0x3b2d9a;},'aUGRa':function(_0x2fc5f8){return _0x2fc5f8();},'SQihu':function(_0x11e778){return _0x11e778();}};if(_0x51c7b8>=0x0&&_0x309568['hEfDj'](_0x51c7b8,questionsData['length'])){if(_0x309568[_0x108bf5(0x3b3)](_0x309568[_0x108bf5(0x2e0)],_0x309568[_0x108bf5(0x139)]))questionStartTime&&(_0x309568[_0x108bf5(0x25a)](_0x309568[_0x108bf5(0x34f)],_0x309568[_0x108bf5(0x34f)])?questionStates[currentQuestionIndex]['timeSpent']+=_0x309568[_0x108bf5(0x364)](Date['now'](),questionStartTime):_0x309568['soEZO'](_0x3fc9f0)),currentQuestionIndex=_0x51c7b8,_0x309568[_0x108bf5(0x2dd)](displayQuestion),_0x309568[_0x108bf5(0xec)](saveProgress);else{const _0x1b0d32=_0x309568[_0x108bf5(0x25a)](_0x34465d[_0x108bf5(0x116)],_0x2c1f89),_0x110749=_0x309568[_0x108bf5(0x25a)](_0x15a06f['id'],_0x4314c5);let _0x59373e=_0x309568[_0x108bf5(0x1d2)];if(_0x110749)_0x59373e=_0x309568[_0x108bf5(0x216)];else{if(_0x1b0d32)_0x59373e=_0x309568['dfePK'];}return _0x108bf5(0x130)+_0x59373e+_0x108bf5(0x37a)+_0x4777b3[_0x108bf5(0x12f)](0x41+_0x336b7)+_0x108bf5(0x32c)+_0x52e1c1['text']+'</span></div>';}}}function updateStats(){const _0x57d075=_0x291fca,_0xdaef0={'sqCBi':function(_0x31065d,_0x289e10){return _0x31065d===_0x289e10;},'qpvAi':_0x57d075(0x393),'cYUFl':_0x57d075(0x205),'GZxSc':_0x57d075(0x307),'oOzhf':function(_0x4e83b4,_0xaff160){return _0x4e83b4>_0xaff160;},'wTcdM':function(_0x43dcf9,_0x443115){return _0x43dcf9*_0x443115;},'tkfCr':function(_0x111fbc,_0x5e1225){return _0x111fbc/_0x5e1225;},'ENsCm':_0x57d075(0x3b0),'yeitD':function(_0x34f0c7,_0x3058bd){return _0x34f0c7+_0x3058bd;},'MYDwy':function(_0x4dc97f,_0x18d482){return _0x4dc97f%_0x18d482;},'GwcTq':_0x57d075(0x2aa),'KAbPC':function(_0x2c759e,_0x4f5f58){return _0x2c759e+_0x4f5f58;}};if(_0xdaef0['sqCBi'](currentMode,_0xdaef0[_0x57d075(0x198)])||_0xdaef0[_0x57d075(0x2a1)](currentMode,_0x57d075(0x2a5))){document[_0x57d075(0x2fd)](_0xdaef0[_0x57d075(0x1bb)])[_0x57d075(0x2a9)]=stats[_0x57d075(0x30e)],document[_0x57d075(0x2fd)](_0x57d075(0x122))['textContent']=stats[_0x57d075(0x2eb)],document['getElementById'](_0xdaef0['GZxSc'])['textContent']=stats[_0x57d075(0x307)];const _0x558e05=_0xdaef0[_0x57d075(0x244)](stats[_0x57d075(0x307)],0x0)?Math[_0x57d075(0x29d)](_0xdaef0['wTcdM'](_0xdaef0[_0x57d075(0x2f4)](stats[_0x57d075(0x30e)],stats[_0x57d075(0x307)]),0x64)):0x0;document[_0x57d075(0x2fd)](_0xdaef0[_0x57d075(0x3a0)])[_0x57d075(0x2a9)]=_0xdaef0[_0x57d075(0x1a9)](_0x558e05,'%'),stats['totalTime']=questionStates[_0x57d075(0x204)]((_0x3cfacf,_0x2bc82f)=>_0x3cfacf+_0x2bc82f[_0x57d075(0x2aa)],0x0);const _0x519583=Math[_0x57d075(0x1d3)](stats['totalTime']/0x3e8),_0x333505=Math[_0x57d075(0x1d3)](_0xdaef0['tkfCr'](_0x519583,0x3c)),_0x44543f=_0xdaef0[_0x57d075(0xf3)](_0x519583,0x3c);document[_0x57d075(0x2fd)](_0xdaef0['GwcTq'])['textContent']=_0xdaef0[_0x57d075(0x1a9)](_0xdaef0[_0x57d075(0x13a)](_0x333505,':'),_0x44543f[_0x57d075(0x14c)]()[_0x57d075(0x1b5)](0x2,'0'));}}function setupVideo(_0x5464f,_0xa9efda){const _0x17cd34=_0x291fca,_0x404a85={'MAROY':_0x17cd34(0x391)};if(Hls[_0x17cd34(0x329)]()){const _0x1c5c17=new Hls();_0x1c5c17['loadSource'](_0xa9efda),_0x1c5c17[_0x17cd34(0x2c6)](_0x5464f);}else _0x5464f[_0x17cd34(0x182)](_0x404a85[_0x17cd34(0x262)])&&(_0x5464f[_0x17cd34(0x2c2)]=_0xa9efda);}function displayQuestion(){const _0x2b22dd=_0x291fca,_0x489cc4={'JCMEP':function(_0x5ae715,_0x524426){return _0x5ae715!==_0x524426;},'XhhvF':'OWpoC','ZFtDd':_0x2b22dd(0x371),'hQUVv':function(_0x1c4c11,_0x121156){return _0x1c4c11===_0x121156;},'QybnV':'div','qFvjS':_0x2b22dd(0x2ae),'hRnVd':function(_0x4ef7ee,_0x501ad4){return _0x4ef7ee+_0x501ad4;},'IRjPS':function(_0x1490eb,_0x605e31){return _0x1490eb+_0x605e31;},'cZGsS':'modeModal','pfGSd':_0x2b22dd(0x2c1),'pObrI':function(_0x41b41a,_0x60938f){return _0x41b41a(_0x60938f);},'Deytb':_0x2b22dd(0x28f),'xsEPP':_0x2b22dd(0x2bf),'DrTcJ':function(_0x3bf98a,_0x26efd6){return _0x3bf98a/_0x26efd6;},'aBvvx':_0x2b22dd(0x385),'rAAZI':function(_0x4c82,_0x3401c1){return _0x4c82+_0x3401c1;},'wupeB':_0x2b22dd(0x2ed),'eXERp':function(_0x2ad470){return _0x2ad470();},'Dqhit':'prevBtn','dPjwg':_0x2b22dd(0x1ea),'Jckuk':_0x2b22dd(0x113),'yJGuK':'questionMedia','eGSXm':_0x2b22dd(0x18a),'JErJN':_0x2b22dd(0x1cf),'ZjVGo':function(_0x311a35){return _0x311a35();},'YqnYe':function(_0x383083,_0x18d576){return _0x383083===_0x18d576;},'ZRiYF':_0x2b22dd(0x2a5),'vRLeY':function(_0x43fde9,_0x25459b){return _0x43fde9===_0x25459b;},'iJmDx':function(_0x2580a5){return _0x2580a5();}};if(!questionsData||questionsData[_0x2b22dd(0x1eb)]===0x0){document[_0x2b22dd(0x2fd)](_0x489cc4[_0x2b22dd(0x15d)])[_0x2b22dd(0x160)]=_0x2b22dd(0x152);return;};const _0x2dc0d6=questionsData[currentQuestionIndex];questionStartTime=Date[_0x2b22dd(0x1f2)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x294ac5=_0x489cc4['DrTcJ'](_0x489cc4[_0x2b22dd(0x246)](currentQuestionIndex,0x1),questionsData[_0x2b22dd(0x1eb)])*0x64;document['getElementById'](_0x489cc4[_0x2b22dd(0x10a)])['style']['width']=_0x489cc4['rAAZI'](_0x294ac5,'%'),document['getElementById'](_0x489cc4['wupeB'])[_0x2b22dd(0x2a9)]=_0x489cc4[_0x2b22dd(0x177)](currentQuestionIndex,0x1),_0x489cc4[_0x2b22dd(0x211)](updateQuestionNav),document[_0x2b22dd(0x2fd)](_0x489cc4[_0x2b22dd(0x308)])[_0x2b22dd(0x36c)]=_0x489cc4['hQUVv'](currentQuestionIndex,0x0),document[_0x2b22dd(0x2fd)](_0x489cc4[_0x2b22dd(0x2fe)])[_0x2b22dd(0x365)][_0x2b22dd(0x242)](_0x489cc4['Jckuk']),document[_0x2b22dd(0x2fd)](_0x489cc4[_0x2b22dd(0x15d)])[_0x2b22dd(0x160)]=_0x2dc0d6[_0x2b22dd(0x33d)]||_0x2b22dd(0x12e);let _0x4831a2='';if(_0x2dc0d6[_0x2b22dd(0x220)])_0x4831a2+=_0x2b22dd(0x1cb)+_0x2dc0d6[_0x2b22dd(0x220)]+_0x2b22dd(0x13b);if(_0x2dc0d6[_0x2b22dd(0x375)])_0x4831a2+=_0x2b22dd(0x189)+_0x2dc0d6[_0x2b22dd(0x375)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';_0x2dc0d6['question_images']&&_0x2dc0d6[_0x2b22dd(0x23f)]['forEach'](_0x2f7980=>{const _0x388f58=_0x2b22dd;if(_0x2f7980)_0x4831a2+=_0x388f58(0x1ba)+_0x2f7980+_0x388f58(0x13f);});document['getElementById'](_0x489cc4[_0x2b22dd(0xeb)])[_0x2b22dd(0x160)]=_0x4831a2;const _0x53a2a8=document[_0x2b22dd(0x2fd)](_0x489cc4[_0x2b22dd(0x2d5)]);_0x53a2a8['innerHTML']='',_0x53a2a8['classList'][_0x2b22dd(0x158)]('answered'),_0x2dc0d6[_0x2b22dd(0x1bd)]&&Array[_0x2b22dd(0x1a4)](_0x2dc0d6[_0x2b22dd(0x1bd)])&&(_0x2dc0d6['choices'][_0x2b22dd(0xf6)]((_0x11ff54,_0x5859a4)=>{const _0x2ceaf3=_0x2b22dd;if(_0x489cc4['JCMEP'](_0x489cc4['XhhvF'],_0x489cc4[_0x2ceaf3(0x398)])){const _0x2394a1=String[_0x2ceaf3(0x12f)](0x41+_0x5859a4),_0x3e7137=_0x489cc4['hQUVv'](selectedOption,_0x5859a4),_0x13362f=document['createElement'](_0x489cc4[_0x2ceaf3(0x21c)]);_0x13362f[_0x2ceaf3(0x160)]=_0x2ceaf3(0x1c0)+(_0x3e7137?_0x489cc4[_0x2ceaf3(0x131)]:'')+_0x2ceaf3(0x30f)+_0x5859a4+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x2394a1+_0x2ceaf3(0x209)+(_0x11ff54[_0x2ceaf3(0x33d)]||_0x489cc4['hRnVd'](_0x2ceaf3(0x18f),_0x489cc4[_0x2ceaf3(0x142)](_0x5859a4,0x1)))+_0x2ceaf3(0x2a0),_0x53a2a8['appendChild'](_0x13362f);}else _0x2ed902[_0x1bc832][_0x2ceaf3(0x2aa)]+=_0x549f46[_0x2ceaf3(0x1f2)]()-_0x513bde;}),_0x53a2a8[_0x2b22dd(0x149)](_0x489cc4[_0x2b22dd(0x2b4)],function(_0x5b7265){const _0x3f239f=_0x2b22dd,_0x25f885={'eLWVu':_0x489cc4[_0x3f239f(0x2a4)],'VInzK':_0x3f239f(0x2d3),'Bgmvx':function(_0x583e1a){return _0x583e1a();}};if(_0x489cc4[_0x3f239f(0x312)]!==_0x3f239f(0x2c1))_0xf34f30=_0x4e1464,_0xc45b49[_0x3f239f(0x2fd)](_0x25f885[_0x3f239f(0x270)])[_0x3f239f(0x173)]['display']=_0x25f885[_0x3f239f(0x2bc)],_0x25f885[_0x3f239f(0x202)](_0x4572ec);else{const _0x3e0e9c=_0x5b7265[_0x3f239f(0x3a3)][_0x3f239f(0x165)](_0x3f239f(0x1ec));if(_0x3e0e9c){const _0x474206=_0x489cc4[_0x3f239f(0x17a)](parseInt,_0x3e0e9c[_0x3f239f(0x1d4)](_0x489cc4[_0x3f239f(0x108)]));_0x489cc4[_0x3f239f(0x17a)](selectOption,_0x474206);}}})),_0x489cc4[_0x2b22dd(0x211)](updateBookmarkButton),_0x489cc4[_0x2b22dd(0x1db)](updateMarkReviewButton),(_0x489cc4[_0x2b22dd(0x366)](currentMode,_0x489cc4[_0x2b22dd(0x137)])||_0x489cc4['vRLeY'](currentMode,'timed_exam'))&&!isQuizCompleted&&_0x489cc4[_0x2b22dd(0x342)](startTimer);}function selectOption(_0x5d4404){const _0x4604d1=_0x291fca,_0x431753={'wXFfP':_0x4604d1(0x2ae),'mfpng':function(_0x305aa1,_0xf04689){return _0x305aa1===_0xf04689;},'DkLXs':'optionsContainer','ECvYQ':'answered','lyCsR':function(_0x5af002,_0x3080bd){return _0x5af002-_0x3080bd;},'bgWUl':'.option-button','sjUIW':function(_0x88eeeb,_0x509ae5){return _0x88eeeb===_0x509ae5;},'PreEN':_0x4604d1(0x393),'vWciz':function(_0x51affd,_0x41e8c4){return _0x51affd===_0x41e8c4;},'chFKA':'timed_study','ZJwJZ':_0x4604d1(0x162),'vliZj':function(_0x540678){return _0x540678();},'RPJGc':function(_0x1147b6,_0x19b11c){return _0x1147b6!==_0x19b11c;},'MiBBf':_0x4604d1(0x348),'EWOyz':_0x4604d1(0x1d0),'nJarW':function(_0x4e3a94,_0x2e308f){return _0x4e3a94!==_0x2e308f;},'wnsiV':_0x4604d1(0x200),'XgrWs':function(_0x435307){return _0x435307();}},_0x102d0d=document[_0x4604d1(0x2fd)](_0x431753[_0x4604d1(0x22d)]);if(_0x102d0d['classList'][_0x4604d1(0x127)](_0x431753[_0x4604d1(0xfc)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x4604d1(0x2aa)]+=_0x431753[_0x4604d1(0x234)](Date['now'](),questionStartTime),questionStartTime=Date[_0x4604d1(0x1f2)]());selectedOption=_0x5d4404,questionStates[currentQuestionIndex][_0x4604d1(0x116)]=_0x5d4404,document[_0x4604d1(0xf4)](_0x431753[_0x4604d1(0x25d)])[_0x4604d1(0xf6)]((_0xa38bc2,_0xd0f64e)=>{const _0x1167f6=_0x4604d1;_0xa38bc2['classList'][_0x1167f6(0x36a)](_0x431753[_0x1167f6(0x2df)],_0x431753['mfpng'](_0xd0f64e,_0x5d4404));});if(_0x431753[_0x4604d1(0x253)](currentMode,_0x431753[_0x4604d1(0x147)])||_0x431753[_0x4604d1(0x26b)](currentMode,_0x431753[_0x4604d1(0x22e)]))_0x431753[_0x4604d1(0x1ee)]!==_0x431753['ZJwJZ']?_0x6b78f7[_0x4604d1(0x160)]+=_0x4604d1(0x2d4)+_0x39cf5e[_0x4604d1(0x350)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':_0x431753[_0x4604d1(0x2de)](processAnswer);else{if(_0x431753[_0x4604d1(0x358)](_0x431753[_0x4604d1(0x2f5)],_0x431753[_0x4604d1(0x2f5)]))_0x5526b=0x0,_0x58b4dd(),_0x2e7cce();else{if(_0x431753[_0x4604d1(0x253)](questionStates[currentQuestionIndex][_0x4604d1(0x286)],_0x431753[_0x4604d1(0x175)])){if(_0x431753['nJarW'](_0x431753[_0x4604d1(0x179)],'KleDt'))questionStates[currentQuestionIndex][_0x4604d1(0x286)]=_0x431753[_0x4604d1(0xfc)],stats[_0x4604d1(0x307)]++,stats['notAttempted']--;else{if(_0x24cf8c){const _0x3e2ade=_0x326192[_0x4604d1(0x15e)](_0x451f87,arguments);return _0xc06e78=null,_0x3e2ade;}}}_0x431753[_0x4604d1(0x3b4)](updateQuestionNav);}}saveProgress();}function processAnswer(){const _0x18ce73=_0x291fca,_0x3e70bc={'cMecS':function(_0x5b9ce6,_0xe0fbd7){return _0x5b9ce6===_0xe0fbd7;},'ZYdiA':_0x18ce73(0x1d0),'HNqPn':_0x18ce73(0x24b),'CJiea':_0x18ce73(0x1f5),'vFlEa':function(_0x51994d,_0x574b88){return _0x51994d(_0x574b88);}},_0x5e7dc8=questionsData[currentQuestionIndex],_0x2b0f8a=_0x5e7dc8[_0x18ce73(0x3ad)];if(_0x3e70bc['cMecS'](selectedOption,null))return;const _0x110177=_0x5e7dc8['choices'][selectedOption],_0xf33576=_0x3e70bc[_0x18ce73(0x195)](_0x110177['id'],_0x2b0f8a);if(_0x3e70bc[_0x18ce73(0x195)](questionStates[currentQuestionIndex][_0x18ce73(0x286)],_0x3e70bc[_0x18ce73(0x390)])){stats[_0x18ce73(0x307)]++,stats[_0x18ce73(0x31e)]--;if(_0xf33576)stats[_0x18ce73(0x30e)]++;else stats[_0x18ce73(0x2eb)]++;}questionStates[currentQuestionIndex][_0x18ce73(0x286)]=_0xf33576?_0x3e70bc[_0x18ce73(0x22f)]:_0x3e70bc['CJiea'],updateStats(),_0x3e70bc[_0x18ce73(0x3b7)](showInlineFeedback,_0xf33576),updateQuestionNav();}function showInlineFeedback(_0xd7cf02){const _0x113ab3=_0x291fca,_0x370163={'GwQdJ':_0x113ab3(0x332),'DQCHc':_0x113ab3(0x3b8),'qfglO':function(_0x599935,_0x3494c9){return _0x599935===_0x3494c9;},'EaAeJ':_0x113ab3(0x34a),'FnrWZ':_0x113ab3(0x120),'dTrrc':'none','WTEAY':_0x113ab3(0x207),'DgYBy':_0x113ab3(0x292),'qoAIK':_0x113ab3(0x2a5),'WWNxT':_0x113ab3(0x113),'yqUxu':function(_0x41a3b1){return _0x41a3b1();},'JVkQf':'selected','GqGMx':_0x113ab3(0x24b),'oMaSl':function(_0x5f32d6,_0x6b5a6e){return _0x5f32d6===_0x6b5a6e;},'kyugJ':_0x113ab3(0x1f5),'rqGrU':function(_0x2c7149,_0x65f130){return _0x2c7149!==_0x65f130;},'zxtuw':_0x113ab3(0x393),'rKEJo':function(_0xda27e9,_0xfd5a8e){return _0xda27e9!==_0xfd5a8e;},'iVPUk':_0x113ab3(0x18a),'mukAX':_0x113ab3(0x1ec),'qphzd':_0x113ab3(0x355),'uvaQi':function(_0x682446){return _0x682446();}};if(_0x370163[_0x113ab3(0x376)](currentMode,_0x370163['zxtuw'])&&_0x370163[_0x113ab3(0x35c)](currentMode,_0x370163[_0x113ab3(0x169)]))return;const _0xf7429e=document[_0x113ab3(0x2fd)](_0x370163['iVPUk']),_0x90707b=_0xf7429e[_0x113ab3(0xf4)](_0x370163[_0x113ab3(0x166)]),_0x170375=questionsData[currentQuestionIndex],_0x5765e5=_0x170375['correct_choice_id'];let _0xf21f91=_0x170375[_0x113ab3(0x1bd)][_0x113ab3(0x1fc)](_0x39fa64=>_0x39fa64['id']===_0x5765e5);_0xf7429e[_0x113ab3(0x365)][_0x113ab3(0x242)](_0x370163[_0x113ab3(0xfb)]),_0x90707b[_0x113ab3(0xf6)]((_0x244053,_0x30636f)=>{const _0x21810a=_0x113ab3,_0x2729a1={'oCweL':'bookmarkBtn','AsiBw':_0x370163['GwQdJ'],'HNWcm':_0x370163[_0x21810a(0x397)],'DFPEu':function(_0x50c55e,_0x443385){const _0x274aff=_0x21810a;return _0x370163[_0x274aff(0x28a)](_0x50c55e,_0x443385);},'NCBuz':function(_0x2ccc16,_0x57d579){return _0x2ccc16===_0x57d579;},'ocPnc':_0x370163[_0x21810a(0x19a)],'lWpkh':_0x370163[_0x21810a(0x1c7)],'OAEhP':_0x370163['dTrrc'],'KUmRl':_0x370163['WTEAY'],'PzrWH':'block','Gbnlc':_0x370163[_0x21810a(0x145)],'hikXP':function(_0x4a5207,_0x145c2f){return _0x370163['qfglO'](_0x4a5207,_0x145c2f);},'sSEhn':_0x370163[_0x21810a(0x169)],'AaItg':_0x370163[_0x21810a(0xef)],'abrCE':function(_0xda92c,_0x2dd339){return _0xda92c>=_0x2dd339;},'XFalU':function(_0x46f9d1){const _0x3567fd=_0x21810a;return _0x370163[_0x3567fd(0x133)](_0x46f9d1);}};if(_0x370163[_0x21810a(0x28a)](_0x21810a(0x353),'hlvzt')){_0x2b562a=_0x45794f[_0x21810a(0x1f2)]();const _0x510d19=_0x34b16f[_0x21810a(0x2fd)](_0x2729a1[_0x21810a(0xe9)]),_0x5ce0c1=_0x8a3742[_0x21810a(0x2fd)](_0x2729a1[_0x21810a(0x18b)]),_0x805840=_0x284508[_0x21810a(0x2fd)](_0x2729a1['HNWcm']),_0x439fd8=_0x2729a1[_0x21810a(0x178)](_0xdbc5be,_0x21810a(0x3af))||_0x2729a1['NCBuz'](_0x5c22d9,_0x2729a1[_0x21810a(0x24a)]);_0xbc7d84[_0x21810a(0x2fd)](_0x2729a1['lWpkh'])[_0x21810a(0x173)][_0x21810a(0x2d8)]=_0x439fd8?_0x2729a1[_0x21810a(0x293)]:_0x21810a(0x2c7),_0x51b411[_0x21810a(0x2fd)](_0x2729a1[_0x21810a(0x3a9)])['style'][_0x21810a(0x2d8)]=_0x439fd8?_0x2729a1['OAEhP']:_0x2729a1['PzrWH'],_0xe2261f['getElementById']('testModeLegend')['style'][_0x21810a(0x2d8)]=_0x439fd8?_0x2729a1[_0x21810a(0x3a6)]:_0x2729a1[_0x21810a(0x293)],_0x54811e[_0x21810a(0x2fd)](_0x21810a(0x335))[_0x21810a(0x173)][_0x21810a(0x2d8)]=_0x439fd8?_0x2729a1['PzrWH']:_0x2729a1[_0x21810a(0x293)],_0x510d19[_0x21810a(0x173)][_0x21810a(0x2d8)]=_0x439fd8?_0x21810a(0x2d3):_0x21810a(0x292),_0x5ce0c1['style'][_0x21810a(0x2d8)]=_0x439fd8?_0x2729a1['Gbnlc']:_0x2729a1[_0x21810a(0x293)],_0x805840[_0x21810a(0x173)][_0x21810a(0x2d8)]=_0x439fd8?_0x21810a(0x292):_0x2729a1[_0x21810a(0x293)],(_0x2729a1[_0x21810a(0x247)](_0x259ad6,_0x2729a1['sSEhn'])||_0x2729a1[_0x21810a(0x279)](_0x1d7059,'timed_exam'))&&_0x530903[_0x21810a(0x2fd)](_0x21810a(0x1e4))[_0x21810a(0x365)]['remove'](_0x2729a1[_0x21810a(0x32a)]),!_0x2bf6e4(_0x3ae74)&&_0x2729a1[_0x21810a(0x3a5)](_0x2b4952,0x0)&&_0x2200a6<_0x69b5c6['length']&&(_0x47301c=_0x5190bd),_0x2729a1[_0x21810a(0x141)](_0x22d0f7),_0x2729a1['XFalU'](_0x57fc8d),_0x2729a1[_0x21810a(0x141)](_0x54d927),_0x12eecd();}else{_0x244053[_0x21810a(0x365)][_0x21810a(0x158)](_0x370163[_0x21810a(0x25f)]);if(_0x30636f===_0xf21f91)_0x244053[_0x21810a(0x365)]['add'](_0x370163[_0x21810a(0x33b)]);else{if(_0x370163[_0x21810a(0x29b)](_0x30636f,selectedOption)&&!_0xd7cf02)_0x244053['classList'][_0x21810a(0x242)](_0x370163[_0x21810a(0x2e4)]);}}}),_0x370163['uvaQi'](showSolution);}function showSolution(){const _0x2b050f=_0x291fca,_0x9b654={'QaPyo':function(_0x14f1b5){return _0x14f1b5();},'JiZoB':function(_0x5cf5e3,_0x2f0b68){return _0x5cf5e3===_0x2f0b68;},'HIRoC':'timed_exam','TOjfK':function(_0x43ff48){return _0x43ff48();},'OHdBa':function(_0xb86e06,_0x45e5a0){return _0xb86e06!==_0x45e5a0;},'tLrBv':function(_0x1b4e35,_0x3eb13f){return _0x1b4e35!==_0x3eb13f;},'vzrzI':_0x2b050f(0x2a5),'bvuXQ':_0x2b050f(0x11f),'DkiZm':_0x2b050f(0x15f),'GMhCS':'solutionVideo','ZqKKm':_0x2b050f(0x33a),'YuPNH':_0x2b050f(0x2e2),'OsUSx':function(_0x4d4364,_0x53a40d,_0x251304){return _0x4d4364(_0x53a40d,_0x251304);},'XiixB':_0x2b050f(0x1f8),'DrzeZ':_0x2b050f(0x113),'YdTJU':_0x2b050f(0x11c),'WRHiG':_0x2b050f(0x285),'eboPa':_0x2b050f(0x3ae)};if(_0x9b654[_0x2b050f(0x239)](currentMode,_0x2b050f(0x393))&&_0x9b654['tLrBv'](currentMode,_0x9b654[_0x2b050f(0x196)]))return;const _0x56866d=questionsData[currentQuestionIndex];document[_0x2b050f(0x2fd)](_0x9b654[_0x2b050f(0x33e)])[_0x2b050f(0x160)]=_0x56866d[_0x2b050f(0x194)]||_0x9b654[_0x2b050f(0x2d6)];const _0x4ce95c=document[_0x2b050f(0x2fd)](_0x9b654['GMhCS']),_0x44aac8=document[_0x2b050f(0x2fd)](_0x9b654['ZqKKm']),_0xb5e3ef=_0x56866d[_0x2b050f(0x399)];if(_0xb5e3ef){_0x4ce95c[_0x2b050f(0x365)][_0x2b050f(0x158)](_0x2b050f(0x113));if(_0xb5e3ef[_0x2b050f(0x39f)](_0x9b654['YuPNH']))_0x9b654[_0x2b050f(0x157)](setupVideo,_0x44aac8,_0xb5e3ef);else _0x44aac8[_0x2b050f(0x2c2)]=_0xb5e3ef;}else _0x9b654[_0x2b050f(0x107)](_0x2b050f(0x1f8),_0x9b654[_0x2b050f(0x256)])?(_0x33ca7e--,_0x9b654[_0x2b050f(0x1f0)](_0x5e970f),_0x3812d5<=0x0&&(_0x5e1129(_0x5b9749),_0x9b654['JiZoB'](_0x4e1301,_0x9b654[_0x2b050f(0x337)])?_0x9b654[_0x2b050f(0x1f0)](_0x11b815):_0x9b654['TOjfK'](_0xee063d))):_0x4ce95c[_0x2b050f(0x365)][_0x2b050f(0x242)](_0x9b654[_0x2b050f(0x370)]);const _0x231056=document['getElementById'](_0x9b654[_0x2b050f(0x17c)]);_0x231056[_0x2b050f(0x160)]='';_0x56866d[_0x2b050f(0x3a7)]&&(_0x231056[_0x2b050f(0x160)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22'+_0x56866d['explanation_audio_eng']+_0x2b050f(0x13b));_0x56866d['explanation_audio_hin']&&(_0x9b654[_0x2b050f(0x239)](_0x9b654[_0x2b050f(0x31a)],_0x9b654[_0x2b050f(0x155)])?_0x231056[_0x2b050f(0x160)]+=_0x2b050f(0x2d4)+_0x56866d[_0x2b050f(0x350)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>':_0x1f0c1b[_0x2b050f(0x352)][_0x2b050f(0xf6)](_0x2ded1f=>{const _0x1c79a7=_0x2b050f;if(_0x2ded1f)_0xad054f[_0x1c79a7(0x160)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x2ded1f+_0x1c79a7(0x2e8);}));const _0x2882cf=document[_0x2b050f(0x2fd)]('solutionImages');_0x2882cf[_0x2b050f(0x160)]='',_0x56866d[_0x2b050f(0x352)]&&_0x56866d[_0x2b050f(0x352)][_0x2b050f(0xf6)](_0x2a4150=>{const _0x1ce23f=_0x2b050f;if(_0x2a4150)_0x2882cf['innerHTML']+=_0x1ce23f(0x38d)+_0x2a4150+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}),document[_0x2b050f(0x2fd)](_0x2b050f(0x1ea))['classList']['remove'](_0x9b654[_0x2b050f(0x370)]);}function _0x2268(_0x189a5a,_0x56909b){const _0x31e6fb=_0x2504();return _0x2268=function(_0x183107,_0x14f47c){_0x183107=_0x183107-0xe8;let _0x3098b7=_0x31e6fb[_0x183107];return _0x3098b7;},_0x2268(_0x189a5a,_0x56909b);}function submitQuiz(){const _0x533171=_0x291fca,_0x3e82c9={'rAght':_0x533171(0x2ae),'VPiCF':_0x533171(0x24b),'yrCnF':function(_0x146850,_0x162284){return _0x146850===_0x162284;},'omUPV':function(_0x2e241d,_0xb3cc57){return _0x2e241d!==_0xb3cc57;},'SDqZw':'timed_study','cRKZY':_0x533171(0x1ec),'pStBK':_0x533171(0x355),'UOuav':function(_0x1e4933){return _0x1e4933();},'VZeil':function(_0x37bad2,_0x299a5c){return _0x37bad2!==_0x299a5c;},'lDGID':_0x533171(0x217),'hEQdP':_0x533171(0x1f5),'Kwajf':function(_0x513595,_0x313d5c){return _0x513595(_0x313d5c);},'gymAu':function(_0x91cc3e,_0x454e78){return _0x91cc3e(_0x454e78);},'SVPxJ':_0x533171(0x254),'SaLYi':function(_0x2c8a7e,_0x44f4ed){return _0x2c8a7e-_0x44f4ed;},'IEgfN':_0x533171(0x17e),'CDwbO':function(_0x11dee5,_0xf0441b){return _0x11dee5-_0xf0441b;},'wpuLr':function(_0x4b4b62){return _0x4b4b62();},'UQBMR':function(_0x196645,_0x5500eb,_0x4454b6,_0x473d58,_0x5d66bf){return _0x196645(_0x5500eb,_0x4454b6,_0x473d58,_0x5d66bf);}};if(timer)_0x3e82c9[_0x533171(0x32f)](clearInterval,timer);if(!_0x3e82c9['gymAu'](confirm,_0x3e82c9[_0x533171(0x1f1)]))return;isQuizCompleted=!![];let _0x4f0c94=0x0,_0x205e96=0x0;const _0x441bb3=_0x3e82c9[_0x533171(0x1e8)](Date['now'](),quizStartTime);questionsData[_0x533171(0xf6)]((_0x14bbee,_0x204835)=>{const _0x33f9af=_0x533171,_0x40d408={'zmPdp':_0x3e82c9[_0x33f9af(0x3bb)],'xvoHk':_0x3e82c9[_0x33f9af(0x172)],'ekbdQ':function(_0xa93e19,_0x38c878){return _0x3e82c9['yrCnF'](_0xa93e19,_0x38c878);},'haTol':function(_0x34a823,_0x37d375){return _0x3e82c9['omUPV'](_0x34a823,_0x37d375);},'UvgJg':function(_0x5c79c9,_0xb4d2e3){return _0x5c79c9!==_0xb4d2e3;},'vqaGe':_0x3e82c9[_0x33f9af(0x3a8)],'kGmnn':_0x33f9af(0x18a),'YPsKz':_0x3e82c9[_0x33f9af(0x3b9)],'xpaHl':_0x3e82c9['pStBK'],'cndDF':function(_0x9b1e43){const _0x2fb389=_0x33f9af;return _0x3e82c9[_0x2fb389(0x1dd)](_0x9b1e43);}},_0x4b46fc=questionStates[_0x204835];if(_0x3e82c9[_0x33f9af(0x394)](_0x4b46fc[_0x33f9af(0x116)],null)){if(_0x3e82c9[_0x33f9af(0x29e)](_0x14bbee[_0x33f9af(0x1bd)][_0x4b46fc['selectedAnswer']]['id'],_0x14bbee[_0x33f9af(0x3ad)]))_0x4f0c94++,_0x4b46fc['status']=_0x3e82c9[_0x33f9af(0x172)];else{if(_0x3e82c9['VZeil'](_0x33f9af(0x217),_0x3e82c9[_0x33f9af(0x27e)])){if(_0x40d408[_0x33f9af(0x237)](_0x427724,_0x33f9af(0x393))&&_0x40d408[_0x33f9af(0x180)](_0x4810fc,_0x40d408[_0x33f9af(0x34e)]))return;const _0x1f642f=_0xe31b4a[_0x33f9af(0x2fd)](_0x40d408[_0x33f9af(0x2b5)]),_0x53f2a7=_0x1f642f[_0x33f9af(0xf4)](_0x40d408['YPsKz']),_0x1257ee=_0x3abfd[_0x33fe62],_0x3dae59=_0x1257ee['correct_choice_id'];let _0x192404=_0x1257ee['choices']['findIndex'](_0x1d0ffb=>_0x1d0ffb['id']===_0x3dae59);_0x1f642f['classList'][_0x33f9af(0x242)](_0x40d408['xpaHl']),_0x53f2a7['forEach']((_0x2e7aba,_0x19fc4b)=>{const _0x11ba7b=_0x33f9af;_0x2e7aba[_0x11ba7b(0x365)][_0x11ba7b(0x158)](_0x40d408[_0x11ba7b(0x2b0)]);if(_0x19fc4b===_0x192404)_0x2e7aba[_0x11ba7b(0x365)][_0x11ba7b(0x242)](_0x40d408[_0x11ba7b(0x296)]);else{if(_0x40d408['ekbdQ'](_0x19fc4b,_0x4b643a)&&!_0x5c41ed)_0x2e7aba[_0x11ba7b(0x365)][_0x11ba7b(0x242)](_0x11ba7b(0x1f5));}}),_0x40d408['cndDF'](_0x48d6ac);}else _0x205e96++,_0x4b46fc[_0x33f9af(0x286)]=_0x3e82c9['hEQdP'];}}});const _0x29c753=JSON[_0x533171(0x26f)](localStorage[_0x533171(0x273)](_0x3e82c9[_0x533171(0x30a)]))||[];_0x29c753[_0x533171(0x20d)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x533171(0x1f2)](),'totalTime':_0x441bb3,'stats':{'correct':_0x4f0c94,'incorrect':_0x205e96,'notAttempted':_0x3e82c9[_0x533171(0x2d9)](questionsData['length'],_0x4f0c94+_0x205e96)}}),localStorage[_0x533171(0x22c)](_0x3e82c9[_0x533171(0x30a)],JSON[_0x533171(0x34b)](_0x29c753)),stats['correctAnswers']=_0x4f0c94,stats['incorrectAnswers']=_0x205e96,_0x3e82c9['wpuLr'](markQuizAsCompleted),_0x3e82c9[_0x533171(0x333)](showPerformanceAnalysis,_0x4f0c94,_0x205e96,questionsData['length']-(_0x4f0c94+_0x205e96),_0x441bb3);}function showPerformanceAnalysis(_0xd9c337,_0x10adc7,_0x38289a,_0x1aa18c){const _0x4704e5=_0x291fca,_0x3f011f={'DQLVN':_0x4704e5(0x1af),'lFuYw':function(_0x38f585,_0x2d5ec3){return _0x38f585>_0x2d5ec3;},'YMkuP':function(_0x1155df,_0x4df69b){return _0x1155df+_0x4df69b;},'eIJFt':function(_0x57639c,_0x2fd5d7){return _0x57639c*_0x2fd5d7;},'qnGIh':function(_0x23f8bd,_0x13e47f){return _0x23f8bd+_0x13e47f;},'duRXl':function(_0x22f559,_0x29093d){return _0x22f559*_0x29093d;},'aBNhL':_0x4704e5(0x1b8),'SaqQq':function(_0x5a58e9,_0x4f0aeb){return _0x5a58e9-_0x4f0aeb;},'InCOK':function(_0x22011d,_0x8c48b0){return _0x22011d*_0x8c48b0;},'lFnQk':function(_0x335987,_0x23fe1d){return _0x335987/_0x23fe1d;},'PjTwa':'notAttemptedResult','EFAdu':_0x4704e5(0x37e),'egKIg':function(_0x4dc1b5,_0x89935f){return _0x4dc1b5/_0x89935f;},'YCqSh':function(_0xd04de3,_0x181564){return _0xd04de3/_0x181564;},'GeIsb':_0x4704e5(0x2be),'vLHGA':_0x4704e5(0x113)},_0x5c40a7=document['getElementById'](_0x3f011f[_0x4704e5(0x210)]),_0x1f3a4a=_0x3f011f['lFuYw'](_0x3f011f[_0x4704e5(0x1c8)](_0xd9c337,_0x10adc7),0x0)?Math[_0x4704e5(0x29d)](_0x3f011f[_0x4704e5(0x1f7)](_0xd9c337/_0x3f011f[_0x4704e5(0x2d1)](_0xd9c337,_0x10adc7),0x64)):0x0,_0x5525a1=_0x3f011f[_0x4704e5(0x1f7)](_0x3f011f['duRXl'](0x2,Math['PI']),0x41),_0x2112bb=document[_0x4704e5(0x2fd)](_0x3f011f[_0x4704e5(0xfe)]);_0x2112bb[_0x4704e5(0x173)][_0x4704e5(0xe8)]=_0x5525a1+'\x20'+_0x5525a1,_0x2112bb[_0x4704e5(0x173)][_0x4704e5(0x146)]=_0x3f011f[_0x4704e5(0x199)](_0x5525a1,_0x3f011f[_0x4704e5(0x266)](_0x3f011f[_0x4704e5(0x15b)](_0x1f3a4a,0x64),_0x5525a1)),document[_0x4704e5(0x2fd)]('accuracyScore')[_0x4704e5(0x2a9)]=_0x1f3a4a+'%',document[_0x4704e5(0x2fd)](_0x4704e5(0x2da))['textContent']=questionsData[_0x4704e5(0x1eb)],document['getElementById'](_0x4704e5(0x223))[_0x4704e5(0x2a9)]=_0xd9c337,document[_0x4704e5(0x2fd)](_0x4704e5(0x367))[_0x4704e5(0x2a9)]=_0x10adc7,document[_0x4704e5(0x2fd)](_0x3f011f['PjTwa'])[_0x4704e5(0x2a9)]=_0x38289a;const _0x2423df=Math[_0x4704e5(0x1d3)](_0x1aa18c/0xea60),_0x59f98a=Math[_0x4704e5(0x1d3)](_0x1aa18c%0xea60/0x3e8);document[_0x4704e5(0x2fd)](_0x3f011f[_0x4704e5(0x37d)])[_0x4704e5(0x2a9)]=_0x2423df+':'+_0x59f98a[_0x4704e5(0x14c)]()[_0x4704e5(0x1b5)](0x2,'0');const _0x1e1811=_0x3f011f[_0x4704e5(0x1ab)](_0x1aa18c,questionsData['length']),_0x3913dc=Math[_0x4704e5(0x1d3)](_0x3f011f['YCqSh'](_0x1e1811,0xea60)),_0x298429=Math[_0x4704e5(0x1d3)](_0x1e1811%0xea60/0x3e8);document[_0x4704e5(0x2fd)](_0x3f011f[_0x4704e5(0x306)])['textContent']=_0x3913dc+':'+_0x298429[_0x4704e5(0x14c)]()['padStart'](0x2,'0'),_0x5c40a7['classList'][_0x4704e5(0x158)](_0x3f011f['vLHGA']);}function closePerformanceModal(){const _0x42b8c9=_0x291fca,_0x287119={'rygwt':'performanceModal','LuXit':_0x42b8c9(0x113)};document[_0x42b8c9(0x2fd)](_0x287119[_0x42b8c9(0x1b6)])[_0x42b8c9(0x365)]['add'](_0x287119[_0x42b8c9(0x15c)]);}function reviewQuestions(){const _0x320e51=_0x291fca,_0x2e50d4={'RlyRP':function(_0x503029,_0x54b353){return _0x503029===_0x54b353;},'PPLPJ':_0x320e51(0x2c3),'yDrdm':'border-red-500','RrXWc':function(_0x336f25,_0x4cd2d8){return _0x336f25+_0x4cd2d8;},'PBEaS':_0x320e51(0x24b),'CzQaV':function(_0x448e24,_0x3cca91){return _0x448e24(_0x3cca91);},'YzWtI':_0x320e51(0x386),'hTcZb':function(_0x399ad1,_0x2e1763){return _0x399ad1!==_0x2e1763;},'exVBv':'Abkfd','Vabcd':_0x320e51(0x35b),'doaCk':'Correct','UkOOM':_0x320e51(0x228),'hPSKi':function(_0x2bae50,_0x536b1e){return _0x2bae50+_0x536b1e;},'Fbspp':_0x320e51(0x128),'boMmm':_0x320e51(0x1f5),'pIZdc':_0x320e51(0x24d),'fUCVf':_0x320e51(0x134),'TsQgf':_0x320e51(0x113),'begca':_0x320e51(0x16f)};document['getElementById'](_0x320e51(0x16e))[_0x320e51(0x365)][_0x320e51(0x158)](_0x2e50d4[_0x320e51(0x3bc)]);const _0x32dcaa=document['getElementById'](_0x2e50d4[_0x320e51(0x2ee)]);_0x32dcaa[_0x320e51(0x160)]='',questionsData[_0x320e51(0xf6)]((_0x54bab4,_0x3baaef)=>{const _0x1c92a3=_0x320e51,_0x4b8be5={'DsZaD':function(_0x23b830,_0x5af54d){const _0x20f374=_0x2268;return _0x2e50d4[_0x20f374(0x255)](_0x23b830,_0x5af54d);},'seobt':_0x2e50d4['PBEaS'],'dgjqo':function(_0x2d6972){return _0x2d6972();},'DSCtD':function(_0x366760,_0x5d71be){const _0xa7dd26=_0x2268;return _0x2e50d4[_0xa7dd26(0x316)](_0x366760,_0x5d71be);}},_0x43cf3f=questionStates[_0x3baaef],_0x3180dc=_0x54bab4[_0x1c92a3(0x3ad)];let _0x498142=_0x1c92a3(0x140),_0x41ad90=_0x2e50d4['YzWtI'];if(_0x2e50d4[_0x1c92a3(0x11e)](_0x43cf3f[_0x1c92a3(0x116)],null)){if(_0x2e50d4[_0x1c92a3(0x11e)](_0x1c92a3(0x167),_0x2e50d4[_0x1c92a3(0x18e)])){const _0x31569c=_0x54bab4[_0x1c92a3(0x1bd)][_0x43cf3f[_0x1c92a3(0x116)]];if(_0x2e50d4['RlyRP'](_0x31569c['id'],_0x3180dc)){if(_0x2e50d4[_0x1c92a3(0x11e)](_0x2e50d4[_0x1c92a3(0x26e)],_0x2e50d4[_0x1c92a3(0x26e)])){const _0x4b991b=_0x305c1f?function(){if(_0xb0c2c3){const _0x49450b=_0x43141a['apply'](_0x4248c7,arguments);return _0x488361=null,_0x49450b;}}:function(){};return _0x49e517=![],_0x4b991b;}else _0x498142=_0x2e50d4[_0x1c92a3(0x38a)],_0x41ad90=_0x2e50d4['doaCk'];}else _0x498142=_0x1c92a3(0x1f5),_0x41ad90=_0x1c92a3(0x1ef);}else{const _0x4ca736=new _0x518338();_0x4ca736[_0x1c92a3(0x1a8)](_0x397588),_0x4ca736[_0x1c92a3(0x2c6)](_0x5a3e4f);}}const _0x31ad6f=document[_0x1c92a3(0x1f4)](_0x2e50d4[_0x1c92a3(0x1df)]);_0x31ad6f[_0x1c92a3(0x28d)]=_0x1c92a3(0x1d6)+_0x498142;let _0x3f7198=(_0x54bab4['choices']||[])[_0x1c92a3(0x27d)]((_0x239191,_0x3c008c)=>{const _0x8fb0ff=_0x1c92a3;if('qgzTM'!==_0x8fb0ff(0x379)){const _0x2baf5a=_0x2e50d4[_0x8fb0ff(0x255)](_0x43cf3f['selectedAnswer'],_0x3c008c),_0x3b0d00=_0x2e50d4[_0x8fb0ff(0x255)](_0x239191['id'],_0x3180dc);let _0x3b1ad3=_0x2e50d4[_0x8fb0ff(0x3a2)];if(_0x3b0d00)_0x3b1ad3=_0x8fb0ff(0x343);else{if(_0x2baf5a)_0x3b1ad3=_0x2e50d4[_0x8fb0ff(0x298)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x3b1ad3+_0x8fb0ff(0x37a)+String[_0x8fb0ff(0x12f)](_0x2e50d4[_0x8fb0ff(0x297)](0x41,_0x3c008c))+'</span><span>'+_0x239191[_0x8fb0ff(0x33d)]+_0x8fb0ff(0x2c8);}else{const _0x4c8f96=_0x5705e6[_0x94de3c],_0x5a7f99=_0x4c8f96['correct_choice_id'];if(_0x4b8be5[_0x8fb0ff(0x356)](_0x1f02b2,null))return;const _0x238eed=_0x4c8f96[_0x8fb0ff(0x1bd)][_0x546b6e],_0x400764=_0x238eed['id']===_0x5a7f99;if(_0x4b8be5[_0x8fb0ff(0x356)](_0x190595[_0x5958cb][_0x8fb0ff(0x286)],_0x8fb0ff(0x1d0))){_0x3b4810[_0x8fb0ff(0x307)]++,_0x1242d8[_0x8fb0ff(0x31e)]--;if(_0x400764)_0x3e06f7[_0x8fb0ff(0x30e)]++;else _0x3635ec[_0x8fb0ff(0x2eb)]++;}_0x2083aa[_0x4905dc]['status']=_0x400764?_0x4b8be5[_0x8fb0ff(0x232)]:_0x8fb0ff(0x1f5),_0x4b8be5[_0x8fb0ff(0x203)](_0x530ab6),_0x4b8be5[_0x8fb0ff(0x136)](_0x29bc53,_0x400764),_0x4b8be5[_0x8fb0ff(0x203)](_0x2ea922);}})[_0x1c92a3(0x150)]('');const _0x4ea297=_0x54bab4[_0x1c92a3(0x399)]?_0x1c92a3(0x176)+_0x3baaef+'\x22\x20data-src=\x22'+_0x54bab4[_0x1c92a3(0x399)]+_0x1c92a3(0x35e):'';let _0x2517d3='';if(_0x54bab4[_0x1c92a3(0x3a7)])_0x2517d3+=_0x1c92a3(0x100)+_0x54bab4['explanation_audio_eng']+_0x1c92a3(0x13b);if(_0x54bab4[_0x1c92a3(0x350)])_0x2517d3+=_0x1c92a3(0x19e)+_0x54bab4[_0x1c92a3(0x350)]+_0x1c92a3(0x13b);let _0x934539=(_0x54bab4['explanation_images']||[])[_0x1c92a3(0x27d)](_0x205432=>_0x205432?'<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x205432+_0x1c92a3(0x2e8):'')[_0x1c92a3(0x150)]('');_0x31ad6f[_0x1c92a3(0x160)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x2e50d4[_0x1c92a3(0x27b)](_0x3baaef,0x1)+_0x1c92a3(0x2b8)+(_0x498142===_0x2e50d4[_0x1c92a3(0x38a)]?_0x2e50d4['Fbspp']:_0x498142===_0x2e50d4[_0x1c92a3(0x143)]?_0x2e50d4[_0x1c92a3(0x248)]:_0x2e50d4['fUCVf'])+'-600\x20text-white\x22>'+_0x41ad90+_0x1c92a3(0x1a7)+_0x54bab4[_0x1c92a3(0x33d)]+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>'+_0x3f7198+_0x1c92a3(0x2f0)+(_0x54bab4[_0x1c92a3(0x194)]||'No\x20solution\x20available.')+_0x1c92a3(0x33f)+_0x4ea297+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x2517d3+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20'+_0x934539+'\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>',_0x32dcaa[_0x1c92a3(0x27c)](_0x31ad6f);}),initializeReviewVideos();}function initializeReviewVideos(){const _0x402d17=_0x291fca,_0x2e4660={'ETbLZ':_0x402d17(0x227),'fBpZX':_0x402d17(0x2e2),'gFVwC':function(_0x1ff881,_0x289bd3,_0x971352){return _0x1ff881(_0x289bd3,_0x971352);},'EgFLU':function(_0x31215f,_0x6e4e83){return _0x31215f===_0x6e4e83;},'juuJZ':_0x402d17(0x125),'nmHqu':function(_0xeeeb4c,_0x3c7f65,_0x14b103){return _0xeeeb4c(_0x3c7f65,_0x14b103);}};document[_0x402d17(0xf4)](_0x2e4660[_0x402d17(0x31d)])[_0x402d17(0xf6)](_0x5aa911=>{const _0x4ed47f=_0x402d17,_0x399ac2={'jLeVs':_0x2e4660[_0x4ed47f(0x319)],'nTPqW':function(_0x108970,_0x1c0905,_0x54ca31){const _0x176512=_0x4ed47f;return _0x2e4660[_0x176512(0x138)](_0x108970,_0x1c0905,_0x54ca31);}},_0x4ddaed=_0x5aa911[_0x4ed47f(0x1a2)][_0x4ed47f(0x2c2)];if(_0x4ddaed&&_0x4ddaed[_0x4ed47f(0x39f)]('.m3u8'))_0x2e4660[_0x4ed47f(0x303)](_0x2e4660[_0x4ed47f(0x39b)],_0x2e4660[_0x4ed47f(0x39b)])?_0x2e4660[_0x4ed47f(0x153)](setupVideo,_0x5aa911,_0x4ddaed):_0x415c3b[_0x4ed47f(0xf4)](_0x2e4660['ETbLZ'])[_0x4ed47f(0xf6)](_0x4c6304=>{const _0x461712=_0x4ed47f,_0x509c54=_0x4c6304[_0x461712(0x1a2)][_0x461712(0x2c2)];if(_0x509c54&&_0x509c54[_0x461712(0x39f)](_0x399ac2[_0x461712(0x381)]))_0x399ac2['nTPqW'](_0x5b32a0,_0x4c6304,_0x509c54);else _0x509c54&&(_0x4c6304[_0x461712(0x2c2)]=_0x509c54);});else _0x4ddaed&&(_0x5aa911[_0x4ed47f(0x2c2)]=_0x4ddaed);});}function retakeQuiz(){const _0x358031=_0x291fca,_0xca607={'kGFOB':_0x358031(0x2ce),'wSeAB':'customQuizData','Uzfnm':function(_0x290640){return _0x290640();}};confirm(_0x358031(0x154))&&(window[_0x358031(0x243)]['pathname'][_0x358031(0x1d1)](_0xca607[_0x358031(0x264)])&&localStorage[_0x358031(0x1e2)](_0xca607[_0x358031(0x1dc)]),_0xca607[_0x358031(0x2db)](clearProgress),location['reload']());}function loadBookmarkedQuestions(){const _0x19fdeb=_0x291fca,_0x47753a={'aPPry':function(_0x2fd63e){return _0x2fd63e();},'gRDFL':function(_0x49b6b0,_0x20d3c7){return _0x49b6b0-_0x20d3c7;},'nQyXv':function(_0x38094f){return _0x38094f();},'VgYIt':function(_0x4e73b7,_0x2b6c50){return _0x4e73b7===_0x2b6c50;},'jBPBs':_0x19fdeb(0x377),'OLSWL':'AJqNR','XngVk':function(_0x58b3de,_0x4b4047){return _0x58b3de<_0x4b4047;},'ZMLmw':'bookmarkedQuestions'},_0x4f19da=JSON['parse'](localStorage['getItem'](_0x47753a[_0x19fdeb(0x2e3)]))||[];_0x4f19da[_0x19fdeb(0xf6)](_0xc2a386=>{const _0x1cf4cd=_0x19fdeb,_0x460176={'TxPFS':function(_0x4dc1af,_0xa0bb7a){const _0x20c0af=_0x2268;return _0x47753a[_0x20c0af(0x23c)](_0x4dc1af,_0xa0bb7a);},'NBeLj':function(_0xb2bbe0){const _0x37a754=_0x2268;return _0x47753a[_0x37a754(0x2d7)](_0xb2bbe0);}};_0x47753a[_0x1cf4cd(0x1fa)](_0x47753a[_0x1cf4cd(0x341)],_0x47753a[_0x1cf4cd(0x341)])?_0xc2a386[_0x1cf4cd(0x20b)][_0x1cf4cd(0x39f)](quizName['toLowerCase']()[_0x1cf4cd(0x231)](/ /g,'-'))&&(_0x47753a[_0x1cf4cd(0xfd)]!=='AJqNR'?_0x47753a[_0x1cf4cd(0x1bf)](_0x211544):_0x47753a[_0x1cf4cd(0x236)](_0xc2a386[_0x1cf4cd(0x1da)],questionsData[_0x1cf4cd(0x1eb)])&&(questionStates[_0xc2a386['questionIndex']][_0x1cf4cd(0x14d)]=!![])):(_0x39b075&&(_0x2bc7f8[_0x308e90][_0x1cf4cd(0x2aa)]+=_0x460176[_0x1cf4cd(0x171)](_0x19299f[_0x1cf4cd(0x1f2)](),_0x14ef8b)),_0x5859d2=_0x556807,_0x3769a2(),_0x460176[_0x1cf4cd(0x14b)](_0x1ce201));});}function toggleBookmark(){const _0x49d790=_0x291fca,_0x2b2fc5={'lhurc':_0x49d790(0x1d5),'PTcgl':'zuCqj','IhfOV':function(_0x15d959,_0x1ff203){return _0x15d959!==_0x1ff203;},'LTEoN':_0x49d790(0x396),'mjirV':function(_0x2123e2){return _0x2123e2();}},_0x37adfc=!questionStates[currentQuestionIndex][_0x49d790(0x14d)];questionStates[currentQuestionIndex]['bookmarked']=_0x37adfc;let _0x5a4fdc=JSON[_0x49d790(0x26f)](localStorage[_0x49d790(0x273)](_0x2b2fc5[_0x49d790(0x14e)]))||[];if(_0x37adfc){if(_0x2b2fc5[_0x49d790(0x251)]!==_0x49d790(0x1d7)){const _0x5e9abf={'quizName':quizName,'quizFile':window[_0x49d790(0x243)][_0x49d790(0x392)][_0x49d790(0x29f)]('/')['pop'](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x49d790(0x1f2)]()};_0x5a4fdc['push'](_0x5e9abf);}else _0x10663a['innerHTML']+=_0x49d790(0x14a)+_0x4b59f4['explanation_audio_eng']+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';}else _0x2b2fc5[_0x49d790(0x267)](_0x49d790(0x21b),_0x2b2fc5[_0x49d790(0x1c3)])?_0x5a4fdc=_0x5a4fdc[_0x49d790(0x135)](_0x291bed=>!(_0x291bed[_0x49d790(0x20b)][_0x49d790(0x39f)](quizName[_0x49d790(0x208)]()[_0x49d790(0x231)](/ /g,'-'))&&_0x291bed['questionIndex']===currentQuestionIndex)):_0x3596cc();localStorage[_0x49d790(0x22c)](_0x2b2fc5['lhurc'],JSON['stringify'](_0x5a4fdc)),_0x2b2fc5[_0x49d790(0x2bb)](updateBookmarkButton),updateQuestionNav();}function updateBookmarkButton(){const _0x509735=_0x291fca,_0x331dce={'dRwDS':'bookmarkBtn','gSLdT':'bookmarkText','VGDmX':_0x509735(0x2ef),'gVfdW':_0x509735(0x19c),'ZYROd':'Bookmark'},_0x5b69fb=document[_0x509735(0x2fd)](_0x331dce['dRwDS']),_0x19001e=document['getElementById'](_0x331dce[_0x509735(0x327)]),_0x4c8a69=questionStates[currentQuestionIndex][_0x509735(0x14d)];_0x5b69fb[_0x509735(0x28d)]=_0x4c8a69?_0x509735(0x346):_0x331dce[_0x509735(0x373)],_0x19001e[_0x509735(0x2a9)]=_0x4c8a69?_0x331dce[_0x509735(0x284)]:_0x331dce[_0x509735(0x2bd)];}function toggleMarkForReview(){const _0x394bf4=_0x291fca,_0x1ad8fc={'dzONm':function(_0xe00392){return _0xe00392();},'LoFiU':function(_0xafd499){return _0xafd499();}};questionStates[currentQuestionIndex][_0x394bf4(0x330)]=!questionStates[currentQuestionIndex]['markedForReview'],_0x1ad8fc[_0x394bf4(0x22b)](updateMarkReviewButton),_0x1ad8fc['LoFiU'](updateQuestionNav);}function updateMarkReviewButton(){const _0x1bfeb6=_0x291fca,_0x1db300={'KEMnk':_0x1bfeb6(0x332),'Rrxdj':_0x1bfeb6(0x2fb),'XplJZ':'Marked','isiPu':_0x1bfeb6(0x263)},_0x5b7731=document['getElementById'](_0x1db300[_0x1bfeb6(0xf1)]),_0x219f46=document['getElementById'](_0x1db300[_0x1bfeb6(0x13e)]),_0x13e262=questionStates[currentQuestionIndex][_0x1bfeb6(0x330)];_0x5b7731[_0x1bfeb6(0x28d)]=_0x13e262?_0x1bfeb6(0x389):'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center',_0x219f46[_0x1bfeb6(0x2a9)]=_0x13e262?_0x1db300[_0x1bfeb6(0xff)]:_0x1db300['isiPu'];}function previousQuestion(){const _0x2921c4=_0x291fca,_0x2d773d={'rtAjL':function(_0x35fa11,_0x299481){return _0x35fa11>_0x299481;},'FiLwr':function(_0x5b4914){return _0x5b4914();},'gDFQq':function(_0x3c8ed6){return _0x3c8ed6();}};_0x2d773d[_0x2921c4(0x3a4)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x2921c4(0x2aa)]+=Date['now']()-questionStartTime),currentQuestionIndex--,_0x2d773d[_0x2921c4(0x3b1)](displayQuestion),_0x2d773d[_0x2921c4(0x181)](saveProgress));}function nextQuestion(){const _0x430694=_0x291fca,_0xc6319b={'mjncf':'div','aaVJb':_0x430694(0x2ae),'wKhxn':_0x430694(0x18f),'OGhHx':function(_0x4bdbd7,_0x3828f6){return _0x4bdbd7+_0x3828f6;},'QtlrY':'.option-button','WRPiV':'data-option-index','KtIwH':function(_0x3dd625,_0x49c18e){return _0x3dd625(_0x49c18e);},'Qicse':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','orImr':function(_0x162597,_0x23c822){return _0x162597===_0x23c822;},'bgUnx':_0x430694(0x283),'IGtXx':_0x430694(0x1e0),'jCFhX':function(_0x22784b,_0x4db0a4){return _0x22784b-_0x4db0a4;},'svOdz':function(_0x4a411b){return _0x4a411b();},'HmPvW':function(_0x21a163){return _0x21a163();},'tqRGD':'test','hBLwc':function(_0x2f810d,_0x2174c5){return _0x2f810d===_0x2174c5;},'MHpSu':_0x430694(0x34a),'mOPtA':_0x430694(0x354),'etmBd':_0x430694(0x33c),'AlsCl':function(_0x1f79d1){return _0x1f79d1();},'cGRDY':function(_0x48f15b,_0x17e07){return _0x48f15b!==_0x17e07;},'ZEvra':'gCRuD','wTjoT':_0x430694(0x2ea)};if(questionStartTime){if(_0xc6319b[_0x430694(0x349)](_0xc6319b[_0x430694(0x163)],_0xc6319b[_0x430694(0x206)])){_0x17fdc8[_0x430694(0x307)]++,_0x161f05[_0x430694(0x31e)]--;if(_0x4bb379)_0x157c8e[_0x430694(0x30e)]++;else _0x2bee3c['incorrectAnswers']++;}else questionStates[currentQuestionIndex][_0x430694(0x2aa)]+=_0xc6319b['jCFhX'](Date[_0x430694(0x1f2)](),questionStartTime);}if(currentQuestionIndex<_0xc6319b[_0x430694(0x26c)](questionsData[_0x430694(0x1eb)],0x1))currentQuestionIndex++,_0xc6319b[_0x430694(0x10d)](displayQuestion),_0xc6319b[_0x430694(0x299)](saveProgress);else{if(_0xc6319b[_0x430694(0x349)](currentMode,_0xc6319b[_0x430694(0x2e7)])||_0xc6319b[_0x430694(0x2fc)](currentMode,_0xc6319b[_0x430694(0x17f)]))_0xc6319b['hBLwc'](_0xc6319b[_0x430694(0x1fb)],_0xc6319b[_0x430694(0x1fb)])?_0xc6319b[_0x430694(0x1d8)](confirm,_0xc6319b['etmBd'])&&_0xc6319b['AlsCl'](submitQuiz):(_0x39e3e2[_0x430694(0x1bd)]['forEach']((_0x1c2d44,_0x238f40)=>{const _0x2704f0=_0x430694,_0x4009f2=_0x33afe2['fromCharCode'](0x41+_0x238f40),_0x43a1c6=_0x484eca===_0x238f40,_0x4e64f1=_0x4e90a7[_0x2704f0(0x1f4)](_0xc6319b[_0x2704f0(0x16b)]);_0x4e64f1[_0x2704f0(0x160)]=_0x2704f0(0x1c0)+(_0x43a1c6?_0xc6319b[_0x2704f0(0x21e)]:'')+_0x2704f0(0x30f)+_0x238f40+_0x2704f0(0x1ed)+_0x4009f2+_0x2704f0(0x209)+(_0x1c2d44[_0x2704f0(0x33d)]||_0xc6319b['wKhxn']+_0xc6319b[_0x2704f0(0x36f)](_0x238f40,0x1))+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20',_0x35a2b1[_0x2704f0(0x27c)](_0x4e64f1);}),_0x2efb6e['addEventListener'](_0x430694(0x1cf),function(_0x47e33b){const _0x486dde=_0x430694,_0x3d2a34=_0x47e33b['target']['closest'](_0xc6319b['QtlrY']);if(_0x3d2a34){const _0x5ede9e=_0x53fa26(_0x3d2a34[_0x486dde(0x1d4)](_0xc6319b['WRPiV']));_0xc6319b[_0x486dde(0x1d8)](_0x18f801,_0x5ede9e);}}));else{if(_0xc6319b[_0x430694(0x1e6)](_0xc6319b['ZEvra'],_0xc6319b[_0x430694(0x268)]))_0x587fed();else{if(confirm(_0x430694(0x20f))){if(_0xc6319b[_0x430694(0x250)]!==_0x430694(0x20a))currentQuestionIndex=0x0,_0xc6319b['svOdz'](displayQuestion),saveProgress();else{const _0x3e14ee=_0x118f98[_0x430694(0x1f4)](_0x430694(0x132));_0x3e14ee[_0x430694(0x2a9)]=_0x2a5bcc+0x1,_0x3e14ee[_0x430694(0x28d)]=_0xc6319b['Qicse'],_0x3e14ee[_0x430694(0x31c)]=()=>_0x59439f(_0x5d9ed6),_0x3e14ee['id']=_0x430694(0x302)+_0x15bf02,_0x3b1305[_0x430694(0x27c)](_0x3e14ee);}}}}}}function startTimer(){const _0x24ecc2=_0x291fca,_0x1605ca={'mYgcJ':function(_0x9c5b56,_0x1e4337){return _0x9c5b56===_0x1e4337;},'dWTmr':'study','YgEku':_0x24ecc2(0x205),'LRHIJ':_0x24ecc2(0x122),'dxWum':_0x24ecc2(0x307),'TVBzJ':function(_0x4e12da,_0x3df364){return _0x4e12da*_0x3df364;},'lXKOP':function(_0x4f0a11,_0x52806a){return _0x4f0a11/_0x52806a;},'rgptq':_0x24ecc2(0x3b0),'DgFmW':function(_0x23c5d7,_0x484272){return _0x23c5d7+_0x484272;},'BIKaF':function(_0x562fa5,_0x4f64a3){return _0x562fa5/_0x4f64a3;},'Ksplu':_0x24ecc2(0x2aa),'XJDEr':_0x24ecc2(0x1d5),'ngiHU':function(_0x43ea91){return _0x43ea91();},'BhNhR':function(_0x5f144c,_0x48e5c5){return _0x5f144c===_0x48e5c5;},'KNGaF':_0x24ecc2(0x291),'oPaZw':function(_0x4ea840,_0x34bebb){return _0x4ea840<=_0x34bebb;},'axhMF':function(_0x60632f,_0x22616c){return _0x60632f===_0x22616c;},'oPVja':_0x24ecc2(0x338),'BvsTf':function(_0x57a0de,_0x31da3c){return _0x57a0de===_0x31da3c;},'hIorO':_0x24ecc2(0x34a),'LdWAl':function(_0x40d10f,_0x189c2d){return _0x40d10f===_0x189c2d;},'LakgI':'jkbUH','SijYJ':function(_0x2cb90b,_0x20a562){return _0x2cb90b(_0x20a562);},'eeOkw':function(_0x323a84){return _0x323a84();},'vlppq':function(_0x3ff57f,_0x4e8543,_0x2af0af){return _0x3ff57f(_0x4e8543,_0x2af0af);}};if(timer)_0x1605ca[_0x24ecc2(0x197)](clearInterval,timer);timeRemaining=0x78,_0x1605ca['eeOkw'](updateTimerDisplay),timer=_0x1605ca['vlppq'](setInterval,()=>{const _0xf885e0=_0x24ecc2;if(_0x1605ca[_0xf885e0(0x115)](_0x1605ca[_0xf885e0(0x277)],_0xf885e0(0xea))){if(_0x1605ca['mYgcJ'](_0x44d347,_0x1605ca[_0xf885e0(0x34d)])||_0x1605ca[_0xf885e0(0x186)](_0x38645f,_0xf885e0(0x2a5))){_0x298299[_0xf885e0(0x2fd)](_0x1605ca['YgEku'])[_0xf885e0(0x2a9)]=_0x4197ac[_0xf885e0(0x30e)],_0x18fd3d[_0xf885e0(0x2fd)](_0x1605ca[_0xf885e0(0x1ff)])['textContent']=_0x155846[_0xf885e0(0x2eb)],_0x1cecef['getElementById'](_0x1605ca[_0xf885e0(0x1e1)])[_0xf885e0(0x2a9)]=_0x407698[_0xf885e0(0x307)];const _0x2051cf=_0x293fd3[_0xf885e0(0x307)]>0x0?_0x286f85[_0xf885e0(0x29d)](_0x1605ca[_0xf885e0(0x1b0)](_0x1605ca[_0xf885e0(0x2f3)](_0x31d9a8[_0xf885e0(0x30e)],_0x500fba[_0xf885e0(0x307)]),0x64)):0x0;_0x2537e2[_0xf885e0(0x2fd)](_0x1605ca[_0xf885e0(0x112)])[_0xf885e0(0x2a9)]=_0x1605ca[_0xf885e0(0x1c1)](_0x2051cf,'%'),_0xa87160[_0xf885e0(0x20c)]=_0x31fc94['reduce']((_0x20ab7d,_0x5c6cc1)=>_0x20ab7d+_0x5c6cc1[_0xf885e0(0x2aa)],0x0);const _0xe41756=_0x6086bf['floor'](_0x4a5905[_0xf885e0(0x20c)]/0x3e8),_0x459827=_0x10bbbd[_0xf885e0(0x1d3)](_0x1605ca[_0xf885e0(0x13d)](_0xe41756,0x3c)),_0x411cd8=_0xe41756%0x3c;_0x4553d6[_0xf885e0(0x2fd)](_0x1605ca[_0xf885e0(0x1a3)])[_0xf885e0(0x2a9)]=_0x1605ca[_0xf885e0(0x1c1)](_0x1605ca[_0xf885e0(0x1c1)](_0x459827,':'),_0x411cd8[_0xf885e0(0x14c)]()[_0xf885e0(0x1b5)](0x2,'0'));}}else{timeRemaining--,updateTimerDisplay();if(_0x1605ca['oPaZw'](timeRemaining,0x0)){if(_0x1605ca['axhMF'](_0xf885e0(0x144),_0x1605ca[_0xf885e0(0x11b)])){const _0x308206=!_0xad1a61[_0x588cac][_0xf885e0(0x14d)];_0x3c2d64[_0x1b773f][_0xf885e0(0x14d)]=_0x308206;let _0x3d684d=_0x846e6e[_0xf885e0(0x26f)](_0x571e66[_0xf885e0(0x273)]('bookmarkedQuestions'))||[];if(_0x308206){const _0x858914={'quizName':_0x36972a,'quizFile':_0x5d1cda[_0xf885e0(0x243)]['pathname']['split']('/')[_0xf885e0(0x28b)](),'questionIndex':_0xb4b2ae,'question':_0x13b844[_0x1ee4d8],'hierarchy':_0x36c620,'timestamp':_0xf53d4b['now']()};_0x3d684d[_0xf885e0(0x20d)](_0x858914);}else _0x3d684d=_0x3d684d[_0xf885e0(0x135)](_0x37d4b3=>!(_0x37d4b3[_0xf885e0(0x20b)][_0xf885e0(0x39f)](_0x23a72a['toLowerCase']()[_0xf885e0(0x231)](/ /g,'-'))&&_0x37d4b3['questionIndex']===_0xf6ed30));_0x2e3d7c[_0xf885e0(0x22c)](_0x1605ca[_0xf885e0(0x2a3)],_0xff7d8a[_0xf885e0(0x34b)](_0x3d684d)),_0x434fce(),_0x1605ca[_0xf885e0(0x1ae)](_0x170aa7);}else{clearInterval(timer);if(_0x1605ca['BvsTf'](currentMode,_0x1605ca[_0xf885e0(0x2fa)])){if(_0x1605ca[_0xf885e0(0x3bd)](_0x1605ca[_0xf885e0(0x269)],_0x1605ca[_0xf885e0(0x269)]))_0x1605ca['ngiHU'](submitQuiz);else{const _0x376e80=_0x386d26[_0xf885e0(0x15e)](_0x34deab,arguments);return _0x16e508=null,_0x376e80;}}else nextQuestion();}}}},0x3e8);}function updateTimerDisplay(){const _0x5c4661=_0x291fca,_0x1c7380={'ysWZV':function(_0x5b34c9,_0x31bc23){return _0x5b34c9/_0x31bc23;},'tbYke':function(_0x1dc4ac,_0x4d9f06){return _0x1dc4ac%_0x4d9f06;}},_0x1ebc1d=Math['floor'](_0x1c7380['ysWZV'](timeRemaining,0x3c)),_0x30f1b8=_0x1c7380[_0x5c4661(0x309)](timeRemaining,0x3c);document['getElementById'](_0x5c4661(0x274))[_0x5c4661(0x2a9)]=_0x1ebc1d+':'+_0x30f1b8[_0x5c4661(0x14c)]()[_0x5c4661(0x1b5)](0x2,'0');}function toggleSidebar(){const _0x186023=_0x291fca,_0x282023={'AfkgL':_0x186023(0x156),'BvPDN':_0x186023(0x109)};document['getElementById'](_0x282023[_0x186023(0x222)])['classList']['toggle'](_0x282023[_0x186023(0x3b5)]);}document['addEventListener']('DOMContentLoaded',()=>{const _0x4579db=_0x291fca,_0x5f0e95={'jCElf':function(_0x317e2a){return _0x317e2a();},'LjRXI':'modeModal','jBIrn':'none','xBXHO':'bVSsx','xLZIv':_0x4579db(0x347),'OvMix':function(_0x3d94f6){return _0x3d94f6();},'HlPam':'custom_quiz.html','QkUwT':function(_0x429eb3){return _0x429eb3();},'PHSZg':_0x4579db(0x292),'zpxiG':function(_0x27461e){return _0x27461e();}};if(resume)_0x5f0e95['jCElf'](loadProgress)?(document[_0x4579db(0x2fd)](_0x5f0e95[_0x4579db(0x148)])[_0x4579db(0x173)]['display']=_0x5f0e95['jBIrn'],_0x5f0e95[_0x4579db(0x185)](initializeQuiz)):_0x5f0e95['xBXHO']!==_0x5f0e95[_0x4579db(0x22a)]?(_0x5f0e95['OvMix'](clearProgress),document[_0x4579db(0x2fd)](_0x5f0e95['LjRXI'])[_0x4579db(0x173)][_0x4579db(0x2d8)]=_0x4579db(0x292)):(_0x7d4559[_0x12f6fa][_0x4579db(0x286)]=_0x4579db(0x355),_0x19b24d[_0x4579db(0x307)]++,_0x5617a8['notAttempted']--);else!window[_0x4579db(0x243)]['pathname'][_0x4579db(0x1d1)](_0x5f0e95['HlPam'])?(_0x5f0e95[_0x4579db(0x129)](clearProgress),document[_0x4579db(0x2fd)](_0x4579db(0x21f))[_0x4579db(0x173)][_0x4579db(0x2d8)]=_0x5f0e95[_0x4579db(0x12d)]):_0x5f0e95[_0x4579db(0x1b2)](initializeQuiz);}),document[_0x291fca(0x149)](_0x291fca(0x1b9),function(_0x491c6c){const _0x285294=_0x291fca,_0x1a9f4c={'wFVSS':_0x285294(0x39c),'CeCab':function(_0x3dfc13,_0x204f87){return _0x3dfc13!==_0x204f87;},'ZOqhi':_0x285294(0x21f),'sloVx':_0x285294(0x2d3),'ttQsL':function(_0x33cdd9,_0x1af82d){return _0x33cdd9===_0x1af82d;},'ggwez':_0x285294(0x1af),'QUALx':function(_0x5d6b1d,_0x4d0abc){return _0x5d6b1d>=_0x4d0abc;},'zBuPg':function(_0x307954,_0xbdac70){return _0x307954<=_0xbdac70;},'QmFGx':function(_0x20d738,_0x399cf6){return _0x20d738-_0x399cf6;},'wChHr':_0x285294(0x1ec),'svYqI':function(_0x45c5fd,_0x1641a8){return _0x45c5fd<_0x1641a8;},'ehaDS':function(_0x398644,_0x4d1868){return _0x398644(_0x4d1868);},'fAVys':_0x285294(0x1e7),'sJAWC':function(_0x37da00){return _0x37da00();},'sYCMA':function(_0x42cf15,_0x116077){return _0x42cf15===_0x116077;},'LYHtx':_0x285294(0x304),'VmlDM':'timed_study','lWxJp':function(_0x5e00c4,_0x43fccc){return _0x5e00c4===_0x43fccc;},'YiObO':_0x285294(0x3af),'yNwLP':_0x285294(0x34a),'GIUli':function(_0x565e7a){return _0x565e7a();},'ORQfm':function(_0x588baf,_0x4b6c28){return _0x588baf===_0x4b6c28;},'CAXJZ':function(_0x41b1b3,_0x201c4a){return _0x41b1b3===_0x201c4a;}};if(_0x1a9f4c['CeCab'](document[_0x285294(0x2fd)](_0x1a9f4c['ZOqhi'])[_0x285294(0x173)][_0x285294(0x2d8)],_0x1a9f4c[_0x285294(0x282)]))return;if(_0x1a9f4c[_0x285294(0x311)](document[_0x285294(0x2fd)](_0x1a9f4c[_0x285294(0x10b)])[_0x285294(0x365)][_0x285294(0x127)](_0x285294(0x113)),![]))return;if(_0x1a9f4c[_0x285294(0x334)](_0x491c6c[_0x285294(0x28c)],'1')&&_0x1a9f4c[_0x285294(0x192)](_0x491c6c[_0x285294(0x28c)],'4')){const _0x2fcffb=_0x1a9f4c[_0x285294(0x11a)](parseInt(_0x491c6c['key']),0x1),_0x6c6e5d=document[_0x285294(0xf4)](_0x1a9f4c[_0x285294(0x360)]);if(_0x1a9f4c[_0x285294(0x35a)](_0x2fcffb,_0x6c6e5d['length']))_0x1a9f4c['ehaDS'](selectOption,_0x2fcffb);}else{if(_0x1a9f4c['ttQsL'](_0x491c6c[_0x285294(0x28c)],_0x1a9f4c[_0x285294(0x106)]))_0x1a9f4c[_0x285294(0x29a)](previousQuestion);else{if(_0x1a9f4c[_0x285294(0x219)](_0x491c6c[_0x285294(0x28c)],_0x1a9f4c[_0x285294(0x190)])||_0x491c6c['key']==='\x20')_0x491c6c['preventDefault'](),nextQuestion();else{if(_0x1a9f4c[_0x285294(0x311)](_0x491c6c[_0x285294(0x28c)][_0x285294(0x208)](),'b')&&(_0x1a9f4c[_0x285294(0x311)](currentMode,_0x285294(0x393))||_0x1a9f4c['sYCMA'](currentMode,_0x1a9f4c['VmlDM'])))_0x1a9f4c[_0x285294(0x26a)](_0x285294(0x34c),_0x285294(0x34c))?_0x40081a=_0x1a9f4c[_0x285294(0x224)]:_0x1a9f4c['sJAWC'](toggleBookmark);else{if(_0x1a9f4c['lWxJp'](_0x491c6c[_0x285294(0x28c)][_0x285294(0x208)](),'m')&&(currentMode===_0x1a9f4c[_0x285294(0x1ad)]||currentMode===_0x1a9f4c[_0x285294(0x10c)]))_0x1a9f4c[_0x285294(0x193)](toggleMarkForReview);else _0x1a9f4c['lWxJp'](_0x491c6c[_0x285294(0x28c)][_0x285294(0x208)](),'s')&&(_0x1a9f4c[_0x285294(0x2f8)](currentMode,_0x1a9f4c[_0x285294(0x1ad)])||_0x1a9f4c[_0x285294(0x105)](currentMode,_0x1a9f4c['yNwLP']))&&submitQuiz();}}}}});</script>

</body></html>